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ABSTRACT
High numbers of US Veterans experience post-traumatic stress disorder (PTSD),
which may occur in combination with chronic pain and depression, and they may face
stressful challenges to daily living. Despite the need, many Veterans do not seek care
following a PTSD diagnosis. In the US, mental health issues fuel over 70% of primary
care visits, and individuals with PTSD often seek treatment in the primary care setting.
Integrated mental health (IMH) models of treatment bring mental health professionals
into the primary care setting, allowing Veterans to receive comprehensive treatment
during primary care visits. The IMH treatment model may bridge the gap for Veterans
with PTSD who need care and those who actually receive it. The present study examined
the impact that IMH has on Veterans with PTSD receiving care from the Veterans Affairs
(VA) health care system. Using several methods of data collection (e.g., medical chart
reviews, VA administrative databases, a mailed survey of patient perception of patientcentered care) the present quasi-experimental evaluation study examined a national
sample of Veterans with PTSD, to evaluate the impact of IMH treatment (as compared to
usual mental health care) on: physical health, mental health, PTSD, health services
utilization, patient perceptions of key patient-centered care constructs, provider
recommendations for treatment, and considerations of patient preferences for treatment.
Outcomes were compared for Veterans receiving IMH vs. usual mental health care, to
assess treatment program impacts; a multivariate logistic regression model was conducted
ix

to assess variables independently associated with IMH treatment receipt, and; mediation
analyses examined whether the relationship between IMH treatment and receipt of
‘adequate’ mental health care is driven by patient perceptions of two important patientcentered care constructs (patient activation; shared medical decision-making).
Collectively, the results of this project indicate that, among Veterans with PTSD
receiving VA health care, IMH treatment receipt is associated with: increased outpatient
and primary care visits; decreased psychotropic medication use; increased
recommendations for complementary and alternative medicine (CAM) (e.g., meditation,
mindfulness and relaxation practices, yoga) treatment modalities; more discussion of
patient preferences for mental health treatment during more VA primary care and mental
health encounters; better patient perceptions of physical health status; greater patient
activation (e.g., engagement in health care), and; better patient perceptions of shared
medical decision-making. However, no meditational relationships were detected.
Combining behavioral health care with traditional primary care through an integrative
mental health treatment model may be most effective in increasing health care
engagement, shared decision-making, and discussion of patient preferences for mental
health care among Veterans with PTSD. As such, these treatment efforts may be effective
in increasing the number of Veterans who receive appropriate, needed health care, as well
as increasing care-related satisfaction. However, data indicate that some targeted
improvement efforts geared toward educating providers about the importance of
discussing and considering patient’s preference for treatment, as well as implementing
systematic collection of standardized measures of symptom severity for common mental
health concerns among Veterans receiving VA health care, may be warranted.
x

Collectively, integrating mental health care providers into the primary care setting may
be a good strategy for encouraging Veterans with PTSD to seek out and stay the course of
the treatment they need.

xi

CHAPTER ONE
POST-TRAUMATIC STRESS DISORDER: THE HISTORY
Long before it received an official name and host of diagnostic criteria,
individuals who experienced or bore witness to traumatic events both experienced and
discussed what is now known as Post Traumatic Stress Disorder (PTSD) (Trimble, 1985).
Prior to the conceptualization of PTSD as an official diagnosis, the psychological
sequelae following exposure to trauma was referred to as various ailments; for instance,
negative psychological reaction following battles as early as the Russian-Japanese War
and World War I were documented as having often been referred to as ‘shell shock’, ‘war
neurosis,’ ‘exhaustion,’ or ‘combat fatigue’ (Mott, 1919; Andreasen, 2004; Croq, 2000) –
a problem that could be overcome through will-power, ‘manliness’ and a renewed sense
of duty to one’s country/military (Bogacz, 1989).
In 1952, the DSM-I was released and contained the first standardized diagnosis of
what would become present-day PTSD: Gross Stress Reaction (Andreasen, 2010;
Andreasen, 2004; American Psychiatric Association (APA), 1952). This disorder,
however, was not included in the subsequent DSM II (Andreasen, 2010; Andreasen,
2004), which instead contained a diagnosis called Adjustment Reaction of Adult Life
(APA, 1968). After decades of returning Vietnam Veterans suffering from what was
casually referred to as ‘Post-Vietnam Syndrome’, the American Psychiatric Association
(APA) instituted a task force to place an official name and set of diagnostic criteria to the
1
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disorder; as such, PTSD was formally introduced in the DMS-III (Andreasen, 2004;
APA, 1980). During this time, the diagnostic criteria for PTSD had undergone several
phases of revisions.
The DSM I criteria for a diagnosis of Gross Stress Reaction, albeit brief, specified
that individuals who did not previously have any previous psychological afflictions may
suffer from this stress disorder after being subjected to great psychological or physical
stress (APA, 1952), however, the criteria specified that if the adverse psychological
reaction lasted longer than a few days to a few weeks, a different diagnosis must be
determined (Andreasen, 2010). Due to a lengthy period of the US not being involved in
war, ‘PTSD’ was not included in the DSM II (Andreasen, 2010; Croq, 2000). However,
the diagnosis for “Adjustment Reaction of Adult Life” included brief descriptions of what
are now considered combat-related hypervigilance and hyper-arousal, as well as reactions
to several other stressors (e.g., car accidents, plane crashes) (APA, 1968).
In light of a great number of Vietnam Veterans suffering from psychological
symptoms for which (collectively) there was no official diagnosis, as well as a plethora of
published literature reporting symptoms of the psychological ramifications of exposure to
extreme stressors/trauma (Kral, 1951; Klein, Zellermayer, & Shanan, 1963; Adler, 1943;
Adler, 1945; Modlin, 1960; Symonds, 1943; Andreasen, 1974; Andreasen, 2010), the
APA introduced PTSD as an official diagnosis in the DSM III (APA, 1980). The sets of
diagnostic criteria for PTSD from the DSM III through the DSM IV-TR were relatively
similar in that they all specified that the afflicted individual must have experienced a
traumatic event, and clustered symptoms into three groups: re-experiencing,
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avoidance/numbing, and hyper-arousal. However, because of the specifications for each
symptom cluster, what constituted a traumatic stressor became more detailed with each
version of the DSM (APA, 1980; APA, 1987; APA, 1994,; APA, 2000). Additionally, the
specification that symptoms must cause “clinically significant distress or impairment in
social, occupational, or other important areas of functioning” was added to the diagnostic
criteria in the DSM IV (APA, 1994; APA, 2000).
In the early days, suggested treatment for what would now be considered PTSD
included moving the individual from the front lines to the back of marching combat
troops to promote psychiatric recovery (Croq, 2000). Shortly thereafter, approaches to
treatment/attempts at therapeutic interventions evolved to methods such as administration
of electroconvulsive therapy (Croq, 2000), finding the afflicted individuals gainful
employment upon their return from the war (Mott, 1919), and providing ‘simple
treatments’ near the front lines of battle with a clear expectation of the afflicted
individual returning to combat [referred to as forward treatment]. This ‘forward
treatment’ method was widely used for cases of PTSD arising during times of combat
from the WWI era through the Vietnam War (Croq, 2000).

CHAPTER TWO
POST-TRAUMATIC STESS DISORDER: THE PRESENT
Since PTSD was first introduced as an official diagnosis in 1980, with the release
of the DSM-III (APA, 1980), the disorder has received an increasing amount of attention
from the medical community, media, and government officials. In the face of the current
conflicts in Iraq and Afghanistan, where combat operations are unique both in respect to
demands on the troops and service members returning home in increasing numbers with
more severe injuries than in any prior conflict (Tanielian, 2008), the issue of
appropriately diagnosing and treating PTSD has become increasingly important.
Diagnostic Criteria
With the release of the DSM-V, both the classification and diagnostic criteria for
PTSD has been revised. Whereas previous versions of the DSM classified PTSD under
the umbrella category of anxiety disorders (APA, 2000), this diagnosis has now been reclassified as a Trauma-and-Stress-or-Related Disorder (APA, 2013). Additionally, the
diagnostic criterion has been expanded from the previous three-factor model of symptom
clusters (e.g., re-experiencing, avoidance and hyper-arousal; APA, 2000) to a four-factor
model (e.g., intrusion, avoidance, negative alterations in cognitions/mood, alterations in
arousal and reactivity; APA, 2013). Further, the diagnostic revision added a specification
for a dissociative sub-type of the disorder, as well as a sub-type for children (6 years of
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age or younger), and removed the need for specification of ‘acute’ or ‘chronic’ (APA,
2013).
PTSD is characterized distinctly by its causal factor and first diagnostic criterion
(criterion A): exposure to a traumatic stressor; the DSM V specifies that the stressor (e.g.,
“death, threatened death, actual or threatened serious injury, or actual or threatened
sexual violence”) may be experienced directly or indirectly (witnessed, as a function of
one’s job or through a close friend/family member) (APA, 2013). Further diagnostic
criteria is as follows: re-experiencing of the trauma; continual avoidance of memoryinducing stimuli regarding the event; altered affect; consistent and out of character hyperarousal or changes in reactivity; and significant distress or impairment in social,
occupational, or other important areas of functioning (APA, 2013). As opposed to the
DSM-IV-TR criteria, the DSM-V criteria does not require that “intense fear, helplessness
or horror happen right after the trauma,” and the criteria no longer classifies the
unexpected passing of a family member or friend as a traumatic event (APA, 2000; APA,
2013).
The minimum symptom duration to meet diagnostic criteria is one month,
however, a diagnostic specification of delayed expression is given if the individual is
diagnosed 6 months or longer after the trauma was experienced, regardless of when (s)he
began experiencing symptoms (APA, 2013). Further, a diagnostic specification of “with
dissociative symptoms” (e.g., depersonalization or derealization) may be given (APA,
2013).

6
Traumatic Stressors (Detailed)
A variety of traumatic stressors can lead to the development of PTSD, and there is
no dichotomous distinction concerning whether an event is or is not traumatizing; rather,
the capacity for a stressor to be traumatizing exists on a continuum (Wilson, 2004). As
asserted by Carlson & Dalenberg (2000), in order for an event to act as a traumatic
stressor it must merely be sudden, negative, and lacking in subjective control for the
individual. As such, PTSD can develop from a vast array of personal, collective, or
witnessed experiences.
In their 1996 study of a representative sample of Detroit residents, Breslau and
colleagues (1998) presented a comprehensive assessment of events considered to be
traumatic stressors, based on diagnostic criteria as defined by the DSM. Their work
provides a comprehensive overview of potential causes of traumatization, and is
comprised of the following: “is/was in military combat; raped or other kinds of sexual
assault; held captive, tortured, or kidnapped; shot or stabbed; mugged, held up,
threatened with a weapon; badly beaten up; in serious car or motor vehicle crash;
involved in any other kind of serious accident or injury; fire, flood, earthquake, or other
natural disaster; diagnosed with a life-threatening illness; one’s child diagnosed as
having a life-threatening illness; witnessed someone being killed or seriously injured;
unexpectedly discovered a dead body; sudden, unexpected death of a close friend or
relative; learned that a close friend/relative. . . was raped or sexually assaulted; was
seriously physically attacked; was seriously injured in a motor vehicle crash; or was
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seriously injured in any other accident” (Breslau, Kessler, Chilcoat, Schultz, Davis, &
Andreski, 1998, p. 4).
Similarly, but more recently, as part of a series of broad mental health surveys,
the World Health Organization (WHO) utilized a list of 29 potential traumatic
experiences. These various types of traumas formed clusters of trauma: being “exposed to
organized violence” (e.g., being a civilian or relief worker in a combat zone); having
“participated in organized violence” (e.g., combat); “interpersonal violence” (e.g., having
been abused as a child, having been mugged); having been a victim of “sexualrelationship violence” (e.g., having been raped or sexually assaulted); having endured
“other life-threatening traumatic experiences” (e.g., accidents, natural disasters); and
having endured “network traumatic experiences” (e.g., unexpected death or trauma of a
loved one) (Kessler, 2014).
Military Service
Despite the wide range of potentially traumatizing events that are not specifically
related to military membership/service, serving in the military is associated with
increased risk of having a traumatic experience (Institute of Medicine (IOM), 2008). In
fact, the United States Department of Veterans Affairs (VA) and Department of Defense
(DoD) (VA/DoD, 2010) have identified general participation in military operations
(above and beyond combat in a designated war zone) as an additional service-related
vehicle of trauma exposure. Traumatic stressors that are specific to participating in
combat operations include, but are not limited to,: “intense emotional demands; extreme
fatigue, weather exposure, hunger, sleep deprivation; extended exposure to danger, loss,
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emotional/physical strain; exposure to environmental hazards, such as toxic
contamination” (VA/DoD, 2010, pp. 17).
When an individual experiences a traumatic event, the initial
psychological/physiological reaction is referred to as an Acute Stress Reaction (ASR)
(APA, 2000; VA/DoD, 2010). While symptoms of an ASR are reminiscent of PTSD,
ASRs are often temporary and will not necessarily lead to a diagnosable case of PTSD. If
symptoms of an ASR last for longer than two days, and are characterized by one
symptom from each of the (previously three) PTSD symptom clusters (e.g., reexperiencing, avoidance/numbing, hyper-arousal) and three symptoms of dissociation, a
diagnosis of Acute Stress Disorder (ASD) is given. ASD can transition into PTSD if
symptoms are present for one month or longer following traumatization (APA, 2000;
VA/DoD, 2010).
Additionally, individuals serving in combat operations may experience a Combat
or Operations Stress Reaction (COSR), which is specifically related to the stress of
military service (in the presence or absence of a distinct trauma) (VA/DoD, 2010). ASD
symptom onset can occur immediately, or as long as several days following the exposure
to trauma, and include (but are not limited to) alterations in mood/energy, depression,
peritraumatic dissociation, substance use, and hyper-arousal. COSR-specific symptoms
focus mainly on alteration in [military-related] occupational functioning, such as
productivity, focus, and motivation (VA/DoD, 2010).
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Symptom Presentation
The presentation of PTSD symptoms is not uniform across the clinical population;
individuals who meet criteria for a PTSD diagnosis can present with a range of subsets of
symptom clusters, in varying levels of severity (IOM, 2008; IOM, 2014). As outlined by
the most recent version of the DSM, there are four main symptom clusters associated
with PTSD: intrusion, avoidance, negative alterations in cognitions/mood, alterations in
arousal and reactivity (APA, 2013). PTSD symptom manifestation can be psychological
and/or physiological in nature (Wilson, 2004). In addition to having experienced a
traumatic stressor, in order to be given a PTSD diagnosis, an individual must present with
the following symptoms:
Intrusion
The cluster of intrusion symptoms is criterion B for diagnosis in the DSM. Five
forms of intrusion are presented in the DSM, with the specification that the symptom(s)
happen “persistently” (APA, 2013). The DSM outlines the following potential symptoms
under this cluster: intrusion can occur in the form of memories of the event (which must
be “recurrent, involuntary and intrusive”), dreams about the event (e.g., nightmares/night
terrors), physiological or psychological reliving of the trauma (e.g., flashbacks),
maladaptive psychological reactions to stimuli related to the event (e.g., anxiety, terror),
and maladaptive physiological reactions to stimuli related to the event (e.g., increased
heart-rate, difficulty breathing) (APA, 2013, p. 467; Wilson, 2004).; An individual must
present with at least one to meet diagnostic criteria (APA, 2013).
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Avoidance
The cluster of avoidance symptoms is criterion C for diagnosis in the DSM. The
DSM outlines two potential avenues through which avoidance can manifest:
psychological avoidance of trauma-related stimuli (e.g., “memories, thoughts, or
feelings”); or, physical avoidance of trauma-related stimuli or stimuli that elicit memories
of the traumatic event (e.g., “people, places, conversations, activities, objects, or
situations”) (APA, 2013). An individual must present with at least one to meet diagnostic
criteria, with the caveat that the individual must not have displayed the behaviors prior to
being exposed to the traumatic event (APA, 2013).
Negative Alterations in Cognitions and Mood
The negative alterations in cognitions and mood symptom cluster is criterion D
for diagnosis in the DSM. The DSM outlines seven potential symptoms under the
negative alterations in cognitions and mood umbrella: amnesia related to the event
(unrelated to substance use or brain injury); negative, consistent and typically
unwarranted thoughts or feelings about oneself specifically or society in general;
consistent and unrelenting self-blame related to the trauma; negative and consistent
feelings about the trauma, such as shame, guilt or anger; loss of interest in “significant
activities” that were previously enjoyable; feeling disconnected from others; inhibited
ability to experience positive emotions (APA, 2013). An individual must present with at
least two symptoms to meet diagnostic criteria, with the caveat that the symptoms must
have been non-existent or markedly less intense prior to exposure to the traumatic event
(APA, 2013).
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Alterations in Arousal and Reactivity
The alterations in arousal and reactivity symptom cluster is criterion E for
diagnosis in the DSM. The DSM outlines five potential symptoms under this cluster.
Alterations in arousal and reactivity can be experienced through: anger/irritability;
behavior that would be considered reckless or self-destructive; hypervigilance; increased
fear-potentiated startle; difficulty concentrating; sleep disturbance (APA, 2013). An
individual must present with at least two symptoms to meet diagnostic criteria, with the
caveat that the symptoms must have been non-existent or markedly less intense prior to
exposure to the traumatic event (APA, 2013).
Criterion F-H (Duration, Functional Significance & Exclusion)
In addition to the specific symptom cluster diagnostic requirements, in order for a
diagnosis of PTSD to be given, the individual must have experienced symptoms for at
least one month, and these symptoms must have caused a significant impairment in the
individual’s social or occupational functioning (APA, 2013). Additionally, it must be
ruled out that symptom presentation is caused by use of controlled or illicit drugs, or
other psychological illnesses (APA, 2013).
Epidemiology and Risk/Resilience
According to results from the U.S. National Comorbidity Survey-Replication, the
lifetime prevalence of PTSD in members of the general population in the U.S. is
approximately 6.8%, with a greater estimated prevalence in women (9.7%) than men
(3.6%) (Gradus, 2014). Specific to the current conflicts, a survey conducted by the
RAND Corporation in 2008 reported a PTSD prevalence of 13.8% among individuals
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who had served in the OEF/OIF combat operations (Gradus, 2014). Other research has
reported PTSD prevalence rates in individuals having served in the OEF/OIF operations
to be as low as 10% and as high as 20% (National Center for PTSD, 2009; IOM, 2014).
Further, PTSD prevalence of 10.1% has been reported among Gulf War Veterans, and
8.1% - 15.2% (female, male, respectively) of Vietnam Veterans (Gradus, 2014). Not
every individual exposed to a traumatic stressor develops PTSD. In fact, literature
suggests that only about one-tenth (Breslau, 2009) to one-third (IOM, 2008) of
individuals exposed to a traumatic stressor will formally develop the disorder.
Risk Factors
Several risk factors for the development of PTSD, both in general and specific to
service members and Veterans have been identified in the literature. For instance, having
an unstable childhood, as well as history of physical or sexual abuse in childhood have
been tied with the development of combat-related PTSD (Castro, 2014). Being of lower
socioeconomic status, intelligence, and education, having a history of previous
trauma/exposure(s) to violence, female gender, having substance abuse problems,
experiencing peritraumatic dissociation at the time of exposure to a traumatic stressor, the
severity of the traumatic event (e.g., combat exposure), having poor coping mechanisms,
having completed a greater number of deployments, undergoing family/life stressors
during deployment, and being divorced are commonly reported variables that increase
risk for or are highly associated with the development of PTSD (VA/DoD, 2010; Brewin,
Andrews, & Valentine, 2000; Shea, Reddy, Tyrka, & Sevin, 2013; Pietrzak, Pullman,
Cotea, & Peter, 2012; Possemato, McKenzie, McDevitt-Murphy, Williams, & Ouimette,
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2014; Phillips, LeardMann, Gumbs, & Smith, 2010; Kline et al., 2013; Booth-Kewley,
Larson, Highfill-McRoy, Garland, & Gaskin, 2010; Hourani et al., 2012; Thomas, Wilk,
Riviere, McGurk, Castro, & Hoge, 2010; Ozer, Best, Lipsey, & Weiss, 2008; Tolin, &
Foa, 2006). Additionally, results from the Millennium Cohort Study (a prospective study
of active duty service members and Veterans that comprises the largest study of this
nature ever conducted within the US military; Castro, 2014) indicate that combat
exposure during deployment results in three times the amount of new cases of PTSD
among service members (vs. those who were not deployed and those who were deployed
but did not experience combat) (Smith, Ryan, Wingard, Slymen, Sallis, & KritzSilverstein, 2008). Some research has even indicated that there may be a genetic
predisposition for developing PTSD (American Public Health Association (APHA),
2013).
Factors that come into play after the traumatic event is experienced, such as life
stressors, including unemployment) and poor social support (along with the trauma
exposure) can contribute to the likelihood that an individual will develop PTSD
(VA/DoD, 2010; Polusny, Erbes, Murdoch, Arbisi, Thuras, & Rath, 2011; Brewin et al.,
2000; Pietrzak et al., 2012; Possemato et al., 2014). Additionally, several military
service-specific factors are associated with the development of PTSD, such as history of
military sexual trauma while in the service (Castro, 2014) and insufficient deployment
training (Schultz, Glickman, & Eisen, 2014; Polusny et al., 2011). For cohorts of service
members who participated in the OEF/OIF operations reported risk factors for the
development of PTSD include lengthy deployments, higher levels of exposure to combat,
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traumatic brain injury, decreased unit support, being a reservist/National Guard member,
and being unmarried (National Center for PTSD, 2011; Polusny et al., 2011; Shen, Arkes,
Kwan, Tan, & Williams, 2010). Recent research has also ascertained that, even for
individuals in non-combat roles, being deployed to a combat theatre increases risk for
post-deployment mental health issues (Peterson, Wong, Haynes, Bush, & Schillerstrom,
2010), and that severity or chronicity of PTSD may be increased if the traumatic event
experienced was created by human acts/behaviors (e.g., combat) (APHA, 2013).
Protective Factors
Studies have also shown a number of factors that are associated with a decreased
risk of developing PTSD after exposure to traumatic stressor. For instance, recent
research conducted with OEF/OIF Veterans suggests that returning service members who
have greater social support, both among their friends and family and among their unit
members, are at a decreased risk of developing PTSD (Pietrzak & Southwick, 2011; Han
et al., 2014; Hourani et al., 2012; Pietrzak, Johnson, Goldstein, & Southwick, 2009).
Additionally, having served as active duty (vs. National Guard), being in a committed
relationship (married to or living with a partner), having a higher level of perceived
control, and having few, if any, problems with psychosocial functioning are associated
with increased odds of resilience to developing PTSD following combat exposure
(Pietrzak & Southwick, 2011; Han et al., 2014). Recent literature also suggests that predeployment resiliency training may be effective at increasing psychological resilience
(Lester, Harms, Herian, Krasikova, & Beal, 2011) and in turn, mitigating the effects of
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combat-related trauma on individuals’ psyches (Hourani et al., 2011; Pietrzak et al.,
2009).
PTSD and Health
Risky Health Behaviors
Recent literature has also indicated that individuals with PTSD are more likely to
engage in risky health behaviors, including engaging in physical altercations which may
lead to physical injury (Widome, Kehle, Carlson, Laska, Gulden, & Lust, 2011), lack of
exercise (APHA, 2013; Zen, Whooley, Zhao, & Cohen, 2012), tobacco use (APHA,
2013; Zen et al., 2012), dangerous driving (Sayer, Noorbaloochi, Frazier, Carlson,
Gravely, & Murdoch, 2010), medication nonadherence (Zen et al., 2012), and misuse of
alcohol (McDevitt-Murphy, Williams, Bracken, Fields, Monahan, & Murphy, 2010).
However, the link between PTSD and poor physical health/increased comorbidities
remains even when such factors are controlled for (Vaccarino et al., 2013).
Mental Health
Literature shows that having PTSD is associated with an increased susceptibility
to having a host of comorbid psychological illnesses and poor health-related quality of
life (APHA, 2013). Specifically, PTSD is associated with higher frequencies of anxiety
disorders (e.g., generalized anxiety disorder, panic disorder, phobias, obsessivecompulsive disorder), depression, bipolar disorder, eating disorders, several personality
disorders, psychotic disorders (i.e., schizophrenia) (APHA, 2013), and sexual dysfunction
(Breyer, Cohen, Bertenthal, Rosen, Neylan, & Seal, 2014). Additionally, PTSD is
associated with substance use disorders, both alcohol and drug-related (APHA, 2013).
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The association between PTSD and comorbid mental health disorders is especially strong
in Veterans with a history of military sexual trauma (Maguen, Cohen, Ren, Bosch,
Kimerling, & Seal, 2012). Recent literature has also shownan association between PTSD
symptom severity and decreased patient-reported mental health status (Asnaani, Reddy,
& Shea, 2014). Additionally, individuals with PTSD and comorbid mental health
conditions tend to experience greater symptom severity and worse outcomes, both in
terms of health (psychological and physiological) and treatment (APHA, 2013).
Physical Health
PTSD has been associated with frequent physiological comorbidities and poor
health (Pacella, Hruska, & Delahanty, 2013; APHA, 2013; Schnurr, & Green, 2004;
Wagner, Wolfe, Rotnitsky, Proctor, & Erickson, 2000). Individuals with PTSD suffer in
high numbers from chronic pain (APHA, 2013; Pacella et al., 2013; Moeller-Bertram,
Keltner, & Strigo, 2012), obesity and metabolic syndrome (APHA, 2013; Pagoto et al.,
2012; Heppner, Lohr, Kash, Jin, Wang, & Baker, 2012), diabetes (APHA, 2013;
Agyemang, Goosen, Anujuo, & Ogedegbe, 2012), dementia (APHA, 2013),
gastrointestinal issues (Pacella et al., 2013; Schnurr, Spiro, & Paris, 2000),
musculoskeletal disorders (Schnurr et al., 2000), skin disorders (Schnurr et al., 2000), and
heart-related diseases, including coronary heart disease, hypertension, myocardial
infarction, hyperlipidemia and cerebrovascular disease (APHA, 2013; Pacella et al.,
2013; Vaccarino et al., 2013; Coughlin, 2011). Additionally, large numbers of individuals
with PTSD concurrently suffer from traumatic brain injuries (TBI) (APHA, 2013).
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Treatment
According to the Institute of Medicine (2008), a wide range of treatment methods
are currently practiced for ameliorating the severity of PTSD symptoms. Individuals may
be treated via medication, therapy, support groups, or even various forms of
complementary and alternative medicine (CAM) (e.g., meditation, mindfulness and
relaxation practices, yoga). Treatment modalities may be administered alone, or in
combination with one another (IOM, 2008).
Medication
Seven classes of pharmacological treatments (and a ‘miscellaneous’ group of
drugs) have been identified in the literature as having been utilized in the treatment of
PTSD (IOM, 2008). These umbrella categories of medication are as follows: alphaadrenergic blockers (e.g., prazosin), anticonvulsants, novel antipsychotics,
benzodiazepines, monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake
inhibitors (SSRIs), and other anti-depressants such as tricyclic antidepressants (TCAs),
noradrenergic and specific serotonergic antidepressants (NaSSAs), and serotonin and
norepinephrine reuptake inhibitors (SNRIs) (IOM, 2008).
According to VA/DoD clinical practice guidelines, however, only SSRIs and
SNRIs are highlighted as being effective means of treatment for the disorder and
recommended for front-line use, with TCAs (fair evidence) suggested as an alternative if
several treatment rounds of SSRIs and SNRIs prove ineffective or cause significant sideeffects (VA/DoD, 2010; VA/DoD, 2013). Additionally, mirtazapine, nefazodone and
monoamine oxidase inhibitors have been rated as having only fair evidence to support
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effectiveness in PTSD treatment (VA/DoD, 2013). A number of other medications have
been rated as ineffective or having insufficient evidence to support recommendation for
use, and recent VA/DoD clinical practice guidelines specify that benzodiazepines may
actually be harmful when used as treatment for PTSD (VA/DoD, 2013).
Therapy
The majority of therapy methods employed in PTSD treatment use variations of
cognitive behavioral therapy (CBT) techniques, and include: exposure therapies, eye
movement desensitization and reprocessing (EMDR), cognitive restructuring, and coping
skills therapy (IOM, 2008). According to the VA/DoD (2010), these forms of therapy are
similar in that they all focus specifically on the trauma, and share many elements; for
example, having the individual face the memories and events related to the trauma,
determining and altering learned and maladaptive cognitions that are a product of the
trauma, and teaching relaxation techniques (VA/DoD, 2010).
Despite the level of overlap that is present, different methods of therapy treatment
do possess unique elements. For instance, exposure therapies are centered around the
individual directly confronting the traumatic event through methods such as in-vivo (i.e.,
a person who is afraid of flying actually boarding an aircraft and flying), imagined,
written, or orated techniques (VA/DoD, 2010; VA/DoD, 2013). Cognitive restructuring
therapies, on the other hand, focus more directly on talking through the learned
cognitions that developed following trauma exposure, and changing those maladaptive
thoughts to adaptive ones (VA/DoD, 2010; VA/DoD, 2013). Finally, EMDR combines
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both exposure and cognition-identification elements with training the individual to
alternate corresponding eye movements (VA/DoD, 2010; VA/DoD, 2013).
An additional form of therapy used in the treatment of PTSD, which encompasses
a bundle of techniques used to combat anxiety, is stress inoculation training (SIT). SIT
teaches individuals to manage reactions of anxiety and maladaptive stress through
techniques such as breathing and relaxation training, thought stopping and positive
thinking (VA/DoD, 2010; VA/DoD, 2013). This treatment bundle entails some CBT
techniques, relaxation skills focused on breathing and muscles, and elements of exposure
therapy, as well (VA/DoD, 2013).
Exposure, cognitive restructuring and SIT are all strongly recommended and
identified as being significantly beneficial in the treatment of PTSD by the VA and DoD,
with other forms of therapy (e.g., group and family therapy, hypnosis) suggested as being
moderately beneficial but not suited as primary methods of intervention (VA/DoD, 2010;
VA/DoD, 2013). Recent clinical practice guidelines suggest that front-line treatment
should begin with a psychotherapeutic approach in tandem with an SSRI or SNRI;
additionally, prazosin may be added to the treatment regimen at any point to help
ameliorate sleep difficulties/nightmares (VA/DoD, 2013).
The VA requires availability of cognitive processing therapy and prolonged
exposure therapy for all Veterans who may need them, and offers many other treatment
options (including CAM treatment modalities) throughout facilities in the VA system of
care. Additionally, the VA requires PTSD screening for all Veteran patients at least once
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a year for the first five years they are receiving care in the VA health care system (IOM,
2014).
Complementary and Alternative Treatment Modalities (CAM)
While VA/DoD clinical practice guidelines rate CAM modalities as not having
enough evidence to recommend them for front-line treatment, modalities that promote
relaxation (such as yoga, mindfulness, acupuncture, etc.) are suggested for supplemental
use to aid in treatment of hyper-arousal symptoms (VA/DoD, 2013). Additionally, these
guidelines suggest that CAM modalities may be considered for amelioration of comorbid
conditions such as chronic pain, and may also be useful in individuals who are resistant to
treatments recommended as front-line options (VA/DoD, 2013).
Patient Preferences for Treatment
As there are multiple treatment options, both front-line recommendations and
CAM treatment modalities, different patients may prefer to receive a specific treatment or
treatment regime over the available alternatives. Taking patients’ preferences and values
into consideration when prescribing a treatment plan is an integral component of
providing care that is patient-centered (IOM, 2001; Barry, & Edgman-Levitan, 2012).
When treatment is aligned with patient preferences, patient are more engaged in their care
(Kwan, Dimidjian, & Rizvi, 2010) and are more likely to be adherent to treatment
(Thompson, & McCabe, 2012). Further, aligning treatment with patient preferences has
been associated with improvements in treatment outcomes (Lin et al., 2005) and reduced
health care costs (Mulley, Trimble, & Elwyn, 2012) and is a goal of the VA (Veterans
Health Administration (VHA), 2014).
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Recent literature has indicated that there may be an association between treatment
preferences, and both adherence to and effectiveness of treatment in PTSD cohorts
(Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008). In the VA, engaging patients in
the decision-making process regarding treatment for PTSD is recommended and
encouraged. In fact, a recent study conducted by Mott and colleagues (2014) found that
an intervention geared toward engaging Veteran patients with PTSD in treatmentdecision making and aligning treatment regiments with patient preferences resulted in
increased initiation of evidence-based psychotherapy and treatment retention (compared
with Veterans with PTSD receiving usual care) (Mott, Stanley, Street, Grady, & Teng,
2014). This study highlights the importance of involving Veterans with PTSD in carerelated decision-making, and taking their preferences into consideration when deciding
upon and initiating a treatment plan.
Health Services Utilization
Given that having PTSD may decrease immune system function (APHA, 2013)
and individuals with PTSD tend to suffer from mental and physiological comorbidities
(APHA, 2013), it is not surprising that use of health services by this population tends to
be high. Veterans with PTSD have significantly greater health services utilization, above
and beyond both Veterans without mental health conditions and Veterans with mental
health conditions other than PTSD (Cohen, Gima, Bertenthal, Kim, Marmar, & Seal,
2010). Even when controlling for factors that could have an impact on health such as
smoking status and physical injury related to the trauma, individuals with PTSD are
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reported to utilize health care services (not including those related to mental health)
significantly more than non-PTSD cohorts (Buckley, Green, & Schnurr, 2004).
Specifically, younger Veterans with a PTSD diagnosis are reported to use
outpatient health services at the VA more frequently than those without PTSD, and
increased symptom severity is also related to greater health-care utilization in Veterans
without documented service-connected disabilities (Calhoun, Bosworth, Grambow,
Dudley, & Beckham, 2002). Similarly, literature has reported that OEF/OIF Veterans
with PTSD seek non-mental health related medical services in the VA significantly more
than both those with other mental health diagnoses and those without any mental health
issues (Cohen, Gima, Bertenthal, Kim, Marmar, & Seal, 2010).
Despite seeing higher use of health services, in general, in the PTSD population,
receipt of adequate mental health treatment is dismally low among Veterans with PTSD
entering the VA system of care (Seal et al., 2010). In fact, recent estimates have
suggested that up to half of service members (Hoge et al., 2014; Quartana et al., 2014)
and high numbers of Veterans (Ouimette et al., 2011; Tanielian, Jaycox, Adamson, &
Metscher, 2008) with PTSD do not seek out needed mental health services, and that
initiation of evidence-based psychotherapy among Veterans with PTSD entering the VA
system of care is extremely low (Shiner et al., 2013).

CHAPTER THREE
STIGMA, MENTAL ILLNESS, AND CARE SEEKING
Stigma Theory and Mental Illness
Perceived stigma associated with mental illness is an enormous barrier to mental
health treatment receipt among military personnel (Hoge et al., 2014; Greene-Shortridge,
Britt, & Castro, 2007) and Veterans (American Psychological Association, 2014) with
psychological concerns. This is concordant with the underlying stigma theory, which
postulates that, in order to avoid the stigma associated with mental illness, individuals
who need mental health care either avoid full participation in care or avoid seeking care
entirely (Corrigan, 2004). Literature describing the social psychology behind stigma, and
the effects of perceived stigma on utilization of mental health services, offers several
potential explanations for why stigma acts as a barrier for treatment seeking behavior.
‘Stigma’ is a social phenomenon in which broad cognitive categories are created
about particular constructs, and are linked to negative stereotypes about that construct;
specifically, stigma has been defined as “the co-occurrence of its components – labeling,
stereotyping, separation, status loss, and discrimination” (Link, & Phelan, 2001). There
are two main attributions? of mental illness that are associated with the stigmatization of
mental illness: (1) ‘stability,’ or how easily changed or treated the illness is and (2)
‘controlability’, or how at-fault the individual is for incurring their illness (Corrigan et al.,
2000). Several common stereotypes that the label of mental illness illicits have been
23
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identified, including that individuals who have psychological disorders are to blame for
their illness, are violent, and are incompetent (Corrigan, 2004). As stereotypes are
cognitive shortcuts that are often processed in the form of quick judgments about large
groups of people, stereotypes tend to lead to prejudice, discrimination and the elicitation
of negative emotions (Corrigan, & Watson, 2002).
Thus, being stigmatized leads individuals to experience loss in two important
domains: self-esteem and social opportunities. Self-esteem is negatively affected in that
the afflicted individual grows to believe and internalize the stereotypes associated with
mental illness and social opportunities are negatively affected in that the individual is
either socially isolated, or regarded with hostility (Greene-Shortridge et al., 2007;
Corrigan, 2004; Corrigan, 1998). When individuals do not seek treatment for their mental
illness, they may be doing so to avoid stigmatization both internally and socially which
they may believe will help avoid loss of self-esteem and social discrimination.
Therefore, stigma is an important vehicle that is preventing individuals with mental
health issues from seeking out needed treatment and/or adhering to a treatment regimen
(Corrigan, 2004).
Stigma As A Barrier for Treatment Seeking in Veterans and Service Members
Recent literature has suggested that there is a vast disparity in the rates of service
members and Veterans with PTSD who are in need of mental health care and those who
receive this needed care (Tanielian, Jaycox, Adamson, & Metscher, 2008, Quartana et al.,
2014; Ouimette et al., 2011). Stigma associated with seeking mental health care has been
cited among the greatest potential barriers to treatment of PTSD in the Veteran
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population (IOM, 2008). In fact, as few as 23-40% of soldiers and Marines who served in
the OEF/OIF directives and screened positive for mental health issues post-deployment
reported having sought out mental health care; these individuals were also found to be at
increased odds for fear of stigmatization associated with seeking mental health care
(Hoge, Castro, Messer, McGurk, Cotting & Koffman, 2004). For instance, of those
Soldiers and Marines who screened positive for mental health issues post-deployment,
65% reported believing that seeking mental health care would lead them to be seen as
weak, 63% believed they would be treated differently by work superiors as a
consequence, 59% believed it would cost them the confidence of their co-workers, and
41% simply found the idea too embarrassing (Hoge et al., 2004).
Several reasons relating to societal and self-stigmatization have been highlighted
in the literature as reasons that Veterans and service members do not seek out mental
health care for PTSD, including: desire to avoid a label of being mentally ill (Mittal,
Drummond, Blevins, Curran, Corrigan, & Sullivan, 2013), not being emotionally ready
(Stecker, Shiner, Watts, Jones, & Conner, 2013), believing treatment is not necessary
(Stecker et al., 2013) and that one should be able to deal with one’s own problems
(Garcia, Finley, Ketchum, Jakupcak, Dassori, & Reyes, 2014), having concerns about
treatment (e.g., not being understood by providers) (Stecker et al., 2013), believing that
seeking treatment is a sign of weakness (Garcia et al., 2014), believing one is at fault for
having PTSD (Mittal et al., 2013), and directly perceiving treatment seeking/receipt as
stigmatizing (Ouimette et al., 2011; Stecker et al., 2013). Additionally, embarrassment is
a commonly cited reason among these cohorts for not seeking mental health care, as are
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ruining chances for promotions within the military and altering the views of one’s peers
(APA, 2014, Hoge et al., 2004). Recent literature has also suggested a potential link
between receipt of mental health treatment and subsequent perceptions of mental health
care associated stigma in OEF/OIF/OND Veterans with PTSD (DeViva et al., 2015).

CHAPTER FOUR
INTEGRATED MENTAL HEALTH
Integrated Mental Health and Patient-Centered Care
In the United States, mental health issues fuel over 70% of primary care visits
(National Association of State Mental Health Program Directors (NASMHPD), 2012),
and individuals with PTSD often seek care in the primary care setting (Stein, McQuaid,
Pedrelli, Lenox, & McCahil, 2000). As alluded to previously, the Institutes of Medicine
defined patient-centered care as “care that is respectful of and responsive to individual
patient preferences, needs, and values, and ensure[s] that patient values guide all clinical
decisions” (IOM, 2001). Important aspects of patient-centered care include chronic care
delivery that is aligned with the chronic care model (Gabbay, Bailit, Mauger, Wagner, &
Siminerio, 2011; Agency for Healthcare Research and Quality (AHRQ), 2010), engaging
patients in their health care (Bechtel, & Ness, 2010; Epstein, & Street, 2011), including
patients in shared medical decision-making (Lee, & Emanuel, 2013; Barry, & EdgmanLevitan, 2012), ensuring that providers exude empathy and communicate clearly and
effectively with their patients (Bechtel et al., 2010; Epstein et al., 2011), and making sure
patients receive timely, accessible care that meets their needs and preferences, and leaves
them satisfied (Barry et al., 2012; Bechtel et al., 2010). According to the Agency for
Healthcare Research and Quality (AHRQ), effectively managing patient’s mental health
concerns is integral to patient-centered care delivery (Croghan, & Brown, 2010), and an
27
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effective, patient-centered strategy includes integrating mental health treatment into
primary care (i.e., ‘integrated mental health’).
Integrated mental health models of treatment bring mental health professionals
into the primary care setting, allowing Veterans to receive comprehensive treatment
during primary care visits (Veterans Health Administration Support Service Center
(VSCC), 2011). This treatment model allows patients to receive behavioral health care
without needing to follow-up on a referral or having to seek treatment at a specialty care
clinic (Karlin, & Zeiss, 2010). The IMH treatment model may reduce stigma associated
with mental health care seeking and expand access options to to care (Collins, Hewson,
Munger, & Wade, 2010; WHO, 2008), potentially bridging the gap for Veterans with
PTSD who need care and those who actually receive it (Corso, Bryan, Morrow,
Appolonio, Dodendorf, & Baker, 2009; WHO, 2008). Both the VA and DoD have
recently begun to implement integrated mental health models of care delivery into
practice (IOM, 2014).
Models of Integrated Care Delivery
Care Management and Co-Located Collaborative Care
The VA, the largest integrated health care system in the country (VHA, 2013),
began a roll-out of the Primary-Care Mental Health Integration (PC-MHI) initiative (e.g.,
integrated mental health treatment) in fiscal-year ‘07 (Post, Metzger, Dumas, &
Lehmann, 2010); PC-MHI care models have been rolled out at a number of VA facilities
(but not all). PC-MHI programs typically have two components: (1) care management, in
which a care manager (typically a nurse or a social worker) monitors patient’s adherence
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to mental health treatment, follows up with patients, and attempts to increase engagement
in and adherence to mental health care, and/or (2) co-located collaborative care, in which
mental health providers are actually embedded into primary care teams, and provide
mental health care to patients in the primary care setting; allowing patients with mental
health concerns to be seen by mental health providers directly in the primary care setting,
so that the mental health treatment seems like it is part of primary care. Most programs
have a combination of both components (co-located, collaborative care – CCC)
(Possemato, 2011).
Examples of care management and co-located collaborative care successfully
implemented within the VA and DoD are as follows: the Behavioral Health Laboratory, a
VA PC-MHI initiative, utilizes the care management model where health care workers
conduct diagnostic interviews, refer patients to specialty mental health clinics, and follow
up with patients regarding their mental health treatment - all via telephone (Pomerantz, &
Sayers, 2010). The Behavioral Health Consultation (BHC) model, which has been
utilized in active duty military settings, utilizes a co-located, collaborative care model in
which primary care providers send patients to mental health providers embedded in the
primary care setting; the mental health providers conduct diagnostic assessments and
brief interventions where appropriate, and provide treatment recommendations to
patient’s primary care providers (who ultimately remain responsible for final care
decisions) (Corso, Bryan, Morrow, Appolonio, Dodendorf, & Baker, 2009). Similarly,
the Three Component Model (3CM) used by the Re-engineering Systems for the Primary
Care Treatment of PTSD (RESPECT-PTSD; RESPECT-Mil) programs is a blended
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model of integrated care, comprised of both co-located, collaborative care and care
management used by the DoD, where a psychiatrist is available to carry out consultations
for primary care providers and manages care managers, on-site care managers follow up
with patients about their mental health care and are available to answer any questions
patients may have, and primary care providers/staff are provided with education
regarding mental health care needs and provision (Engel et al., 2008; Schnurr et al.,
2013).
Brief Interventions Designed for Use in Primary Care
In addition to models of integrated mental health care delivery, several brief
interventions are discussed in the literature as appropriate for use in integrated mental
health settings, though providing such services in the primary care setting is a somewhat
new phenomenon (Funderbunk & Shepardson, 2015; Butler et al., 2008). One example of
this type of intervention is Behavioral Activation (BA); BA is based on the tenets of
cognitive behavioral therapy, but focuses on re-engaging patients with PTSD in the
activities that they were conditioned to avoid following trauma exposure (Jakupcak,
Wagner, Paulson, Varra, & McFall, 2010). Another example is a brief Written Emotional
Disclosure (WED)/Combat Writing intervention (Possemato, 2011), which involves
having patients compose written narratives of their traumatic experiences. To facilitate
use in the primary care setting, these interventions are typically short in terms of length
and number of sessions required.
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Differences Between Traditional and Integrated Mental Health Care
As opposed to usual/traditional mental health care, where a patient is referred to a
mental health provider/clinic and must follow up on a referral (or seek out a visit of their
own volition), PC-MHI visits typically begin with a seamless “warm hand-off” from a
patient’s primary care provider to a mental health provider located in close proximity in
the primary care setting, if the patient’s primary care provider believes that individual has
mental health concerns (based on results of brief mental health screenings done by the
primary care provider or other indications given by the patient), and the patient is
agreeable to seeing the co-located mental health provider.
Visits in this setting (as compared to specialty (usual care/traditional) mental
health settings), are typically shorter in duration, and patients are usually seen by the
mental health provider in this setting a fewer number of times (Dundon, Dollar, Schohn,
& Lantinga, 2011; Possemato, 2011); individuals who require more intensive care are
then referred out to specialty mental health clinics (usual/traditional care). This type of
focused, succinct treatment model may greatly improve mental health treatment retention,
while simultaneously opening up specialty mental health treatment resources to
individuals who require more intensive care (Pomerantz et al., 2010).
Use and Outcomes of Integrated Mental Health
Recent literature has supported the efficacy of integrated mental health in
improving symptoms, (e.g., mental health, general health, quality of life) for cohorts with
various mental health issues such as depression (Kroenke, Shen, Oxman, Williams, &
Dietrich, 2008; Fortney et al., 2007; Chowdhury, Kulcsar, Gilchrist, & Hawkins, 2012)
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and generalized anxiety disorder (Roy-Byrne et al., 2010; Chowdhury et al., 2012). For
instance, receiving integrated mental health treatment has been associated with
improvements in important health outcomes such as glycated hemoglobin, low-density
lipoprotein (LDL) cholesterol, and systolic blood-pressure levels in patients with chronic
conditions (e.g., diabetes, coronary heart disease (CHD), or both) and comorbid
depression (Katon et al., 2010). Further, a recent review of integrated mental health
studies in individuals with mental health disorders (mainly depression and anxiety,
though this review also identified research focused on the use of integrated mental health
in ADHD, alcohol abuse and somatization cohorts) conducted by the AHRQ found that
integrated mental health treatment models resulted in greater improvements in depression
and anxiety symptoms (over usual care), improved quality of life, and higher treatment
satisfaction (Butler et al., 2008).
Integrated Mental Health in Veterans/Service Members
Literature suggests that integrated mental health may increase likelihood of
patients receiving an initial (full) diagnostic evaluation for mental health and/or social
services needed (e.g., beyond the brief screening evaluations that are required for all
patients) (Seal, Cohen, Bertenthal, Cohen, Maguen, & Daley, 2011). Integrated mental
health program participation may also improve mental health care continuation among
Veterans with mental health diagnoses initiating VA care (Bohnert, Pfeiffer, Szymanski,
& McCarthy, 2013). Integrated mental health is associated with treatment retention in
mental health care (Tsan, Zeber, Stock, Sun, & Copeland, 2012), adherence to
pharmacological treatment in Veterans with depression (Fortney et al., 2011) and
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increased utilization of specialty mental health services (Wray, Szymanski, Kearney, &
McCarthy, 2012), as treatment modalities may still fall under the specialty care umbrella
and/or patients may be more likely to follow up on referrals for care in specialty mental
health clinics, indicating use of needed/prescribed services. Additionally, recent studies
have found that integrated mental health treatment models may optimize recognition and
diagnosis of mental health disorders (Zivin et al., 2010), and reach typically underserved
populations in behavioral health care (Johnson-Lawrence et al., 2012) in the Veteran
population.
Integrated mental health treatment delivery has been shown to decrease pain and
depression severity in Veteran patients with chronic pain receiving care from the VA
(Dobscha et al., 2009). Further, a study by Cucciare and colleagues (2013) found that a
brief behavioral health intervention delivered in primary care to Veterans with substance
abuse (specifically, alcohol) may foster improvements in use of appropriate coping
mechanisms, depression severity, and mental health status (as compared to usual care)
(Cucciare, Boden, & Weingardt, 2013).
Integrated Mental Health and Veterans/Service Members with PTSD
Among the factions that comprise the DoD, all service branches are implementing
integrated mental health programs in order to reduce barriers to mental health care for
members of the military (including those with PTSD) (IOM, 2014). Additionally, as
mentioned, the VA health care system began rolling out integrated mental health care in
facilities throughout the national health care system in FY07 (Post, Metzger, Dumas, &

34
Lehmann, 2010). Despite the need, however, limited evidence exists about the effects of
integrated mental health treatment delivery in Veterans and service members with PTSD.
Gellis et al. (2010) examined mental health diagnoses, PTSD symptom severity,
depression severity, and health status in 201 OEF/OIF Veterans with PTSD receiving
care from the Behavioral Health Laboratory (BHL) at the Philadelphia and Lebanon VA
Medical Centers (VAMCs). The Veterans in the study sample (receiving care via the
BHL) were classified as having full (e.g., meet diagnostic criteria as outlined by the
DSM) (59.7%) or partial (e.g., have PTSD symptoms but do not meet full DSM
diagnostic criteria; ‘sub-threshold’ PTSD) (18.4%) PTSD, or minimal/no PTSD
symptoms (despite having experienced trauma (21.9%)). Physical health status was
similar across PTSD groups, but composite mental health scores were worse in Veterans
with full PTSD (vs. partial and no PTSD). Veterans with full PTSD reported significantly
worse depression symptoms than those with partial PTSD (whose depression scores were
also worse than Veterans with no PTSD). Presence of comorbid panic disorder and
bipolar disorder were associated with PTSD classification (Gellis, Mavandadi, & Oslin,
2010).
Similarly, Kornfield and colleagues (2012) examined PTSD symptom severity,
severity of comorbid depression, and health status in Veterans with sub-syndromal PTSD
receiving IMH care through the BHL at the Philadelphia VAMC. This cohort of
Veterans, who received care via the IMH treatment model, did not meet full diagnostic
criteria for PTSD, but scored between 40-60 on the PTSD Checklist – Civilian Version
(PCL-C) and reported having experienced trauma. Outcomes were examined overall, and
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comparisons were made between OEF/OIF/Operation New Dawn (OND) Veterans and
non-OEF/OIF/OND Veterans. Comorbid depression was reported in approximately 44%
of the sample, however, it was less prevalent in the OEF/OIF/OND cohort (36.7%) than
the non-OEF/OIF/OND cohort (47.9%). Of the overall sample, only 28% endorsed
avoidance symptoms, 80% endorsed arousal symptoms, and 86% endorsed reexperiencing symptoms. A greater proportion of the OEF/OIF/OND Veterans endorsed
arousal symptoms, while a lesser proportion endorsed avoidance symptoms; there were
no differences in frequency of re-experiencing symptom cluster endorsement. Not
surprisingly, OEF/OIF/OND Veterans reported better physical health scores than the nonOEF/OIF/OND cohort, while mental health was similar across Veterans groups
(Kornfield, Klaus, McKay, Helstrom, & Oslin, 2012).
Brawer and colleagues (2011) conducted a retrospective chart review of 471
OEF/OIF Veterans who received consults to the OEF/OIF-specific PTSD clinic at the St.
Louis VAMC between 01/01/2009 and 06/30/2010. Outcomes examined were consult
completion, consult accuracy (diagnostic and administrative accuracy), length of
engagement in care prior to consultation, and PTSD symptom severity and depression
severity (at time of consult). Veterans whose consults were placed by PC-MHI providers
were compared to those who received consults from PCPs, specialty mental health, or
providers from other parts of the hospital (e.g., emergency department, medical clinics).
Veterans referred by PC-MHI providers (vs. other provider types) did not differ in terms
of PTSD and depression severity, and number of clinic visits prior to consultation.
Significantly more Veterans referred to the OEF/OIF PTSD clinic by PC-MHI providers
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(vs. PCPs) completed their consults and had accurate consults administratively, however,
no differences in diagnostic accuracy of consults placed by PC-MHI providers (vs. PCPs)
were found (Brawer et al., 2011).
Similarly, Possemato et al. (2011) conducted retrospective chart reviews to
examine need for treatment (positive VA mental health screens), physical and psychiatric
health conditions, service use and prescribed medications in Veterans with PTSD
receiving PC-MHI services compared to those receiving specialty mental health or
primary care services only. PTSD was most commonly addressed in PC-MHI sessions
(main focus in 72% of session), with mood (42%) and anxiety (13%) disorders the next
most common. Veterans who started in PC-MHI and switched to specialty mental health
(vs. those who stayed in PC-MHI) were more likely to be Vietnam Veterans, service
connected, had more psychiatric diagnoses and PTSD visits, and were prescribed more
medication (Possemato et al., 2011).
Additionally, Vojvoda and colleagues (2014) conducted a retrospective cohort
administrative database analysis comparing Veterans with PTSD who received integrated
mental health treatment in primary care to those who received care through specialty
mental health clinics. Contradictory to previous studies, results indicated that most
Veterans were seen in specialty mental health clinics, and the authors postulate that
stigma may not, in fact, be driving Veterans with PTSD to seek out mental health care in
the primary care setting. Results did, however, show that more Veterans receiving their
care in specialty mental health clinics were receiving pharmacological treatment (vs.
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Veterans receiving integrated mental health care) (Vojvoda, Stefanovics, & Rosenheck,
2014).
Recently, Bohnert et al. (2016) also conducted a retrospective cohort
administrative database study, wherein records for over 21,000 Veterans who screened
positive for PTSD and received either primary care, PCMHI, or specialty mental health
care on the day of screening. Findings indicate that being seen by a PCMHI provider on
the day of a positive PTSD screen was associated with greater odds of being diagnosed
with PTSD, and initiating treatment for PTSD (Bohnert, Sripada, Mach, & McCarthy,
2016).
Further, Hoerster and colleagues (2015) adapted the Translating Initiatives for
Depression into Effective Solutions (TIDES) model of care management for Veterans
with depression for use in OEF/OIF Veterans with PTSD (TIDES/PTSD). The care
management program was delivered via telephone to 17 OEF/OIF Veterans with PTSD.
Results indicated high patient satisfaction, and decreased PTSD symptom severity,
following participation in the program (Hoerster et al., 2015).
A small number of studies have also examined outcomes for Veterans who
received integrated mental health treatment through a treatment model adapted from the
RESPECT-D framework, an integrated treatment model (3CM) that was shown to be
effective in treating depression. Schnurr et al. (2013) found no differences in PTSD or
depression severity change in Veterans who received 3CM compared to those who
received usual care. However, Veterans who participated in the intervention had higher
mental health care utilization and rates of filling prescriptions for antidepressant
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medication. While many Veterans rated the care they received through 3CM highly, the
intervention arm was associated with lower perception of PTSD-specific care.
Among a cohort of active duty military personnel, however, Engel and colleagues
(2008) found that, in individuals who received 3CM treatment, clinically significant
reductions in PTSD symptom severity were realized in 67% of participants at 6-10 week
follow-up and 81% at 12-week follow-up, and clinically significant reductions in
depression were realized in 48% of participants at 6-10 week follow-up and 63% at 12week follow-up. Only about 21% of this sample, however, had PTSD, indicating that
findings may not be entirely generalizable to the PTSD population.
Additionally, a handful of studies have examined outcomes among active duty
military personnel receiving collaborative mental health/primary care. Cigrang and
colleagues (2011) reported that, among active duty OEF/OIF personnel, PTSD and
depression severity, along with global mental health functioning, improved following
integrated mental health treatment. In fact, of those who completed treatment, half no
longer met diagnostic criteria for PTSD at follow-up. Currently, the first randomized
controlled trial examining implementation of integrated mental health in service members
with PTSD and/or depression is underway, and will provide outcomes and impact of
internally facilitated vs. externally facilitated integrated mental health (Engel et al.,
2014).
A number of studies have also examined the effects of brief mental health
interventions designed for use in and administered in primary care for cohorts of
Veterans/service members with PTSD. Corso et al. (2009) examined two brief
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interventions (5 sessions of combat writing or impact statement compared with usual
care) delivered in an integrated mental health setting on PTSD symptoms and global
mental health in active duty military personnel. Significant reductions in PTSD severity
and global mental health following treatment were realized. Specifically, individuals who
received the impact statement intervention experienced significant reductions in PTSD
symptoms and global mental health, written emotional disclosure participants
experienced a reduction in PTSD symptoms (but non-significant) and, surprisingly, a
decline in global mental health (but also non-significant), and usual care receipt resulted
in no symptoms change for PTSD or global mental health.
Additionally, several studies have examined outcomes among Veterans with
PTSD who received brief mental health interventions delivered in (or designed to be
delivered in) primary care settings. Harmon et al. (2014) examined the effectiveness of a
brief (three to four 20-minute sessions) trauma intervention with cognitive-behavioral
therapy components delivered in a VA PC-MHI clinic. Of their sample, approximately
82% were diagnosed with PTSD. No significant improvements in PTSD severity were
found, but decreases in severity of depression and anxiety were realized. Additionally,
improvements in subsequent specialty mental health treatment engagement were
reported.
Jakupcak and colleagues (2010) examined the effects of a behavioral activation
(BA) intervention provided in the primary care setting on PTSD severity in OEF/OIF
Veterans with PTSD and depression. The BA intervention consisted of 8 treatment
sessions. Significant decreases in PTSD symptoms over time, as measured by both the
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Clinician-Administered PTSD Scale (CAPS) and the PCL-Military Version (PCL-M),
were seen in Veterans who received the BA intervention; these effects were true for both
Veterans who completed all 8 sessions of the intervention and those who completed only
4 sessions. Of the 5 Veterans who completed all 8 sessions, symptom reduction was
maintained at 3-month follow-up in 4. Reduction in depression severity and increase in
reported quality of life were reported for study participants, but were not significant.
Additionally, reported satisfaction with care was high among Veterans who received this
treatment.
Similarly, Plagge and colleagues (2013) examined the effectiveness of an
integrated treatment intervention with BA (IMPROVE) for OEF/OIF/OND Veterans with
PTSD and comorbid chronic pain. Comparing pre-treatment to post-treatment levels,
Veterans reported decreases in PTSD symptom severity, pain severity, and pain
interference. Veterans who completed the intervention also reported improvements in
depression, quality of life and satisfaction with life, and pain catastrophizing and
kinesiophobia. Veterans also reported high levels of satisfaction with treatment.
Possemato et al. (2011) reported PTSD and depression severity, problematic
alcohol use, health status and participant satisfaction in a group of OEF/OIF Veterans
who participated in a brief intervention comprised of written emotional disclosure
delivered via telehealth. No significant differences were found in outcomes from pre-topost-intervention, however, authors mention that a lack of sufficient power may have
caused inability to detect meaningful differences even if they were there.

CHAPTER FIVE
STUDY OBJECTIVES
The primary purpose of this study was to examine the impact of a novel model of
mental health care delivery, integrating mental health into primary care, on outcomes of
Veterans with PTSD receiving care from the VA health care system. This model of care
has been cited as a potential way to reduce stigma attached to seeking mental health care,
which in turn may increase health care seeking, treatment engagement, and expand access
options to care. In the literature, integrated mental health treatment models have shown
positive impacts on mental and physiological health outcomes, and appropriate health
care utilization, in civilian cohorts with mental illnesses, as well as Veterans and service
members with psychological health concerns. Some recent research has indicated that this
treatment model may have positive mental and physical health, and appropriate health
care utilization, effects on individuals with PTSD, including Veterans and service
members. Despite the importance, however, evidence of the impact of this relatively new
and potentially beneficial model of health care delivery in Veterans and service members
with PTSD is scarce. Using several methods of data collection (e.g., medical chart
reviews, VA administrative databases, surveys) the overall goal of the present study was
to assess the impact of integrated mental health care (as compared to usual mental health
care) on important health, treatment utilization and patient-centered care outcomes in a
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national sample of Veterans with PTSD who received treatment in the VA health care
system and were new users of mental health care.
Hypotheses
Hypothesis 1
Veterans with PTSD receiving integrated mental health care (vs. Veterans with
PTSD receiving usual mental health care) will have more appropriate mental health care
utilization, better physical and mental health outcomes, lower pain, and lesser PTSD
symptoms.
Hypothesis 1a. Veterans with PTSD receiving integrated mental health care (vs.
Veterans with PTSD receiving usual mental health care) will have more appropriate
mental health care utilization. More appropriate mental health care utilization was
defined as: more needed mental health visits, prescribed pharmacology use, fewer
hospitalizations, but more primary care visits. Literature indicates that receiving IMH
care is associated with mental health care continuation among Veterans with mental
health diagnoses initiating VA care (Bohnert, Pfeiffer, Szymanski, & McCarthy, 2013),
treatment retention in mental health care (Tsan, Zeber, Stock, Sun, & Copeland, 2012),
adherence to pharmacological treatment in Veterans with depression (Fortney et al.,
2011) increased utilization of specialty mental health services (Wray, Szymanski,
Kearney, & McCarthy, 2012), decreased preventable hospitalizations among Veterans
with mental illness (Pirraglia, Kilbourne, Lai, Friedmann, & O’Toole, 2011), increased
primary care and specialty medical care visits, but no differences in ER visits, among
Veterans with depression (Engel, Malta, Davies, & Baker, 2011).
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Hypothesis 1b. Veterans with PTSD receiving integrated mental health care (vs.
those receiving usual mental health care) will have better physical health (e.g., fewer
visits with poor health indicators, higher self-reported physical health (VR-12) scores
(where available) and lower pain scores (as recorded in the patient’s medical record).
Poor health indicators were defined as diastolic blood pressure ≥ 90 and systolic blood
pressure ≥ 140 (hypertension); Hemoglobin A1c ≥9% (diabetes); LDL ≥ 130
(Hyperlipidemia). Less pain was defined as the average pain rating (0-10 scale) provided
by patients during their medical visits, as recorded in the patient’s medical record.
Literature indicates that receiving care via the IMH treatment model has been associated
with improvements in important health outcomes such as glycated hemoglobin A1c,
cholesterol, and blood-pressure levels in patients with chronic conditions (e.g., diabetes,
coronary heart disease (CHD) or both) and comorbid depression (Katon et al., 2010).
Additionally, literature indicates that IMH treatment delivery has been shown to decrease
pain in Veteran patients (Dobscha et al., 2009).
Hypothesis 1c. Veterans with PTSD receiving integrated mental health care will
have lower depression symptom severity (where applicable), and higher self-reported
mental health scores (VR-12; where available) than Veterans with PTSD receiving usual
mental health care. Depression severity was defined as the patient’s last recorded PHQ-9
score (as recorded in the patient’s medical record, when available). Literature indicates
that receiving care via the IMH treatment model may help to relieve symptoms of
depression in Veteran patients receiving VA health care (Dobscha et al., 2009).
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Hypothesis 1d. Veterans receiving integrated mental health care will endorse
fewer PTSD symptoms, and have lower overall symptom severity, than Veterans
receiving usual mental health care. For this hypothesis, PTSD symptoms were derived
from provider progress notes recorded in the patient’s medical record, as classified by the
DSM V diagnostic criteria, and may have included symptoms of avoidance, intrusion,
negative alterations in cognitions and mood, and/or alterations in arousal and reactivity.
Symptom severity was defined as PTSD-Checklist (PCL) scores, as recorded in the
patient’s medical record, where available. Literature indicates that treatment receipt via
an IMH model reduces PTSD symptom severity in active duty military personnel (Engel
et al., 2008; Cigrang et al., 2011).
Hypothesis 2
Patient perceptions of patient-centered care constructs will be higher among
Veterans with PTSD receiving integrated mental health care than those receiving usual
mental health care Patient perceptions of patient-centered care constructs were defined as
patient’s CEPEP survey responses for the following constructs: care alignment with the
chronic care model as measured by the Patient Assessment of Chronic Illness Care scale,
treatment engagement as measured by the Patient Activation Measure, provider empathy
and patient-provider communication as measured by the Consultation And Relational
Empathy measure, overall experience with the health care facility as measured by the
Global Practice Experience measure, shared decision-making as measured by the
Combined Outcome Measure for Risk Communication and Treatment Decision Making
Effectiveness, and respect for choices and support as measured by the Press-Ganey
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questions. Though literature examining patient-centered care outcomes in relation to
IMH treatment receipt is sparse, hypothesized differences between cohorts in this study
are expected because the IMH treatment model is a patient-centered model of mental
health care delivery, indicating that Veterans with PTSD receiving IMH care should
receive care that is more patient-centered compared to Veterans receiving usual mental
health care.
Hypothesis 3
Veterans receiving integrated mental health care will be recommended to more
psychotherapy and CAM treatment options by their providers, whereas Veterans
receiving usual mental health care will be recommended to more pharmacology treatment
options. Literature indicates that more Veterans with PTSD receiving their care in
specialty mental health clinics were prescribed pharmacological treatment (vs. Veterans
receiving integrated mental health care), as evidenced by greater number of psychotropic
prescriptions filled (Vojvoda, Stefanovics, & Rosenheck, 2014).
Hypothesis 4
As one of the central tenets of PCC within the VA health care system is that
health care will be personalized, proactive, and take into account what matters most to
patients, patient preferences for treatment will be taken into consideration by providers
more often for Veterans receiving integrated mental health care (vs. usual mental health
care). Assessment of patient preferences for treatment were made based on a
comprehensive assessment of the content of progress notes across the course of
treatment; an example of a patient preferences is if a patient tells their provider that they
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do not wish to participate in pharmacological treatment because they medication they are
on gives them side-effects; the provider may either accommodate the patient’s preference
(e.g., recommend an alternative, non-pharmacological treatment option) or recommend
treatment that is not concordant with what the patient wants (e.g., insist the patient stays
the course of the medication).
Hypothesis 5
Patient perceptions of two important patient-centered care constructs associated
with health services utilization, including mental health services (e.g., shared decisionmaking; patient activation) will mediate the relationship between type of mental health
treatment (integrated vs. usual care) and receipt of necessary recommended PTSD
treatment (9 or more visits within 1 year of treatment initiation).

CHAPTER SIX
METHODS
This quasi-experimental study used mixed methods to evaluate the impact of
integrative mental health treatment delivery on physical health, mental health, PTSD,
health services utilization, patient perceptions of patient-centered care, provider
recommendations for treatment, and considerations of patient preferences for treatment.
Under the supervision of Dr. LaVela, a team of Health Services Research and
Development (HSR&D) researchers at the VA conducted a large-scale, national
evaluation study to examine the spread and reach of patient-centered care innovations in
the VA system of care [Center for Evaluation of Practices and Experiences of PatientCentered Care (CEPEP), PEC 13-002, PI: LaVela]. This project was classified as a
Quality Improvement project by the VA Central IRB.
A portion of the current study involved a survey comprised of measures of several
patient-centered care constructs, which was mailed to Veterans who had received care at
one of 8 VA health care facilities nation-wide, from mid-FY12 (May 2012) through
11/15/2012. This study drew upon Dr. LaVela’s evaluation. The population for the
current study began with the larger general Veteran cohort to which CEPEP surveys were
mailed (our initial pool of eligible Veteran patient participants).
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Participants
Of the 16,425 Veterans that comprised the final CEPEP sample, individuals that
were included in the cohort of participants for the present study were identified using the
following method (please see Table 1):
(1) Veterans who had two documented PTSD diagnoses (2 instances of the ICD-9
code 309.81 in their medical record, which is the diagnosis code for PTSD) from the
beginning of FY12 (October 1, 2011) – 12/31/2012 were identified using VA Inpatient
and Outpatient administrative data.
(2) Integrative Mental Health users were identified as individuals who had a
documented clinic stop of 534 or 539 in either the primary or credit position, or credit
pairs 527/534, 182/534, 323/531, from the beginning of FY12 – 12/31/2012. Clinic stop
codes are used within the VA to document and track patients’ use of specific outpatient
health services, and can be coded as a single number or a pair of numbers, where the first
number is said to be in the primary position and the second number is said to be in the
credit position; when a code is in the primary position, this indicates that the primary
reason for the visit was use of that particular service. When the code is in the credit
position, this indicates that the use of that service was the secondary reason for the visit.
The first integrated mental health care visit in that time frame was used as the index visit,
and all subsequent mental health visits were considered ‘integrated’ care.
(3) ‘Usual Mental Health Care’ users were identified as individuals who had a
documented clinic stop code of 502-599 (the clinic stop codes for mental health care
visits, e.g., care received at mental health clinics) from the beginning of FY12 (October

49
1, 2011) – 12/31/2012, excluding 586 and 587 (residential care) and any credit pair of a
stop code in the 500s with 534 or 539 in the credit position (such that no individuals who
were in the integrated mental health group were included in the usual care group). The
first mental health visit in that time frame was used as the index visit; of our preidentified cohort of eligible study participants, 112 Veterans were excluded because they
had no Mental Health care during the timeframe.
(4) Individuals were identified as ‘new users’ of mental health care if they had not
had a previous mental health visit in the two years preceding, leaving 311 Veterans
eligible Veterans (126 integrated mental health care users and 185 usual mental health
care users); Veterans who had used both integrated mental health and specialty mental
health services were considered to fall into the integrated mental health care group, as all
care subsequent to integrated mental health care initiation should be integrated.
Table 1. Sample Derivation
CEPEP sample with 2 PTSD flags
PTSD
2213
No PTSD
13960
CEPEP sample with 2 PTSD flags by mental health care use
Integrated Mental Health
551
Usual Mental Health Care
2027 *1550
CEPEP sample with 2 PTSD flags and no mental health care use in 2 years prior to index
date
Integrated Mental Health
126
Usual Mental Health Care
289 *185
*Represents Usual Mental Health Care only
(5) In order to better ensure that groups for comparison were equivalent, and to
rule out potential selection effects which may have been present due to the quasiexperimental nature of the study, patients in the usual mental health care group were
matched on age and number of comorbid mental health conditions to patients in the
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integrated mental health care group. Comorbid mental health conditions were identified
by ICD-9 codes in the range of 290-319 present in the patient’s medical record, which is
the range of ICD-9 codes used to document diagnosis of mental health conditions. The
final sample was 234 Veteran patients (117 in each group). [Please see Figure 1 for a
flow-chart delineating the population selection process]
Procedure and Materials
Data for the current study were obtained from several sources: VA administrative
data, medical record chart review, and the mailed national patient survey conducted as
part of the CEPEP evaluation efforts. See Appendix A for a table detailing variables and
sources (which are also described below).
Administrative Data
Information regarding health services utilization, select comorbid mental and
physical health conditions, and demographics was obtained from VA administrative
databases (and supplemented with CEPEP survey data (in the case of demographics)),
where available, to minimize the amount of missing data. The VA Corporate Data
Warehouse (CDW) is a national database comprised of data from VHA clinical and
administrative systems, which are stored such that all data can be merged at the patient
level. Data included in the CDW include information about all inpatient and outpatient
care, as well as the content of patient’s electronic health records. CDW data are refreshed
nightly, allowing close monitoring of included data, such as utilization trends.
Administrative data collected in the CDW was pulled and analyzed for all 234 Veterans
in the final cohort of this study. For this study, the CDW was used to capture

51
demographic data, chronic conditions, mental health diagnoses, mental health and general
health services utilization, and physical and mental health indicators.
Medical Chart Abstraction
Information regarding severity of comorbid mental health conditions, frequency
and severity of PTSD symptoms, and provider recommendations for treatment was
obtained via medical chart review abstraction. Medical chart reviews are a data collection
method which involves scanning progress notes in patient’s medical records for data
relevant to health care and health care visits (Jaén et al., 2010), For the current study,
medical chart reviews were conducted to gather additional information related to
participant’ PTSD symptoms, providers’ treatment recommendations (and patient
preferences for treatment), and severity of comorbid mental health conditions,
information which is not available via administrative databases. The content of
physicians’ and nurses’ notes, documented in patient’s electronic health record, may offer
additional detail about the frequency and severity that participants experienced PTSD
symptoms, as well as provider referrals to various potential treatment options (e.g.,
pharmacology, psychotherapy, CAM), and details about the trajectory of any mental
health comorbidities the patient may be experiencing.
Medical chart reviews were conducted with a random sample of 45 individuals
from the integrative mental health group and 45 individuals from the usual mental health
care group (90 chart review ‘participants’ total). Chart reviews started with an index date
(the patient’s first integrated mental health or usual mental health care visit); all mental
health and primary care notes were reviewed from the index date through the subsequent
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year. Data were systematically extracted using a form developed by the researcher
(Etingen), which was revised based on several test cases (see Appendix B). For each
patient participant, one ‘cover sheet’ was filled out overall, and one chart review form
was completed for each visit that the patient has in the chart review time period.
In order to assess inter-rater reliability, a 10% sample of the chart reviews were
conducted by an independent member of the research team; a reliability check was then
done to make sure both individuals were conducting the chart reviews in the same way.
An a-priori criterion of 85% inter-rater reliability was set for the overall chart review
assessment tool. Inter-rater reliability was investigated by calculating the proportion of
agreement (or the number of times the two reviewers agreed on the presence or absence
of the criterion in each of the notes); agreement between the two reviewers was very
high, with an overall proportion agreement of 98%.
Survey Data
Information on self-reported health status and patient perceptions of several
patient-centered care constructs was obtained for a sub-set of the sample using data from
the mailed national survey conducted as part of the CEPEP evaluation efforts. The
CEPEP patient survey was sent to a national sample of Veteran patients in
February/March of 2013. The survey packet was comprised of several measures of
patient-centered care constructs, and was sent along with a cover letter explaining the
study and a postage paid return envelope to facilitate ease of response. A follow-up
mailing was conducted in May/June of 2013 with non-respondents, to facilitate response.
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Surveys were sent to 16,425 general Veteran patients. The denominator was
adjusted to 15,629, as 674 surveys were returned as undeliverable, 77 Veterans on the
initial mailing list were deceased, 42 Veterans indicated the survey was not applicable to
them, and 3 surveys were returned to us unopened. Surveys were returned by 5,512
Veteran patients (35.27% response rate). Of our cohort, completed surveys were
available for 30 Veterans in the integrated mental health group and 31 Veterans in the
usual mental health care group (n=61 Veterans total).
Measures/Variables
Demographics, Veteran Characteristics and Select Health Conditions
Demographic and characteristic variables collected were: gender (male, female);
age; race (white, black, Asian, native Hawaiian/ other Pacific Islander, American
Indian/Alaska Native, other); ethnicity (Hispanic/Latino, non-Hispanic/Latino);
relationship/marital status (married, not married); service connected disability percentage
(0%, 1-49%, 50-100%), number of select chronic conditions; multimorbidity (≥2 chronic
conditions); and select mental health diagnoses. Chronic conditions assessed and
included in the count used to identify multimorbidity were based on 5 chronic conditions
indicated by the CDC as being among the top causes of mortality in the US, and
included: heart disease, cancer, chronic lower respiratory disease, stroke and diabetes
(CDC, 2013). ICD-9 codes (slightly modified from those used by Jemal and colleagues,
2005) used to identify presence of these disorders can be found in Appendix A (Jemal,
Ward, Hao, & Thun, 2005).
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Comorbid mental health diagnoses were obtained via administrative data. For
these psychosocial disorders, ICD-9 codes, classified into groups using the general
classifications documented in the Agency for Health Research and Quality’s (AHRQ)
Clinical Classifications Software (Elixhauser, Steiner, & Palmer, 2008), a method that
has been previously used to examine mental health diagnoses in Veterans, with minor
adjustments (e.g., examining PTSD on its own rather than with other anxiety disorders;
combining alcohol and substance use disorders; examining bi-polar and depressive
disorders separately rather than combined as the more general group of ‘mood disorders’)
(Pavao et al., 2013). Mental health diagnoses examined included: adjustment disorders,
anxiety disorders, PTSD, impulse control disorders (including pathological gambling),
bipolar disorders, depressive disorders, personality disorders, schizophrenia and other
psychotic disorders, substance use disorders, and suicide and intentional self-injury.
Information on whether or not Veterans had a documented history of military sexual
trauma was also be collected. (See Appendix A for a full description of ICD-9 codes
included in each diagnosis category).
Health Services Utilization
Utilization variables assess whether integrative mental health fosters an increase
in adequate mental health care utilization (defined as 9 or more mental health treatment
visits within 12 months of the patient’s index visit for patients with PTSD; Lu, Duckart,
O’Malley, & Dobscha, 2011). Mental health utilization was examined through the
following indicators: outpatient visits related to mental health services, prescription
psychotropic medication fills, and visits specifically associated with a number of mental
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health conditions (a visit was considered to be for a particular condition if the primary
diagnosis code for that visit was an ICD-9 code for that condition).
Further, data on general health care utilization (including mental health care
utilization, which was also pulled out and reported separately) was also be examined, and
included: inpatient encounters (hospitalizations); average length of stay; outpatient visits
(general) and specifically primary care visits [and number of no-shows to scheduled
primary care visits]; emergency department visits; prescription medication fills (general).
Additionally, patients’ number of visits for several select physical were tracked (a visit
was considered to be for a particular condition if the primary diagnosis code for that visit
was an ICD-9 code for that condition).
Physical Health
Proxy measures (indicators) of physical health were obtained via administrative
databases, and included: blood pressure (hypertension); Hemoglobin A1c (diabetes);
LDL (Hyperlipidemia). The number of visits associated with indicators of poor health for
these conditions were recorded. For blood pressure, systolic blood pressure ≥ 140 and
diastolic blood pressure ≥ 90 indicates poor health (American Heart Association, 2014).
For Hemoglobin A1C: HbA1c ≥9% indicates health (US Department of Health and
Human Services). For Low Density Lipids (LDL): LDL ≥ 130 indicates poor health
(National Heart, Lung and Blood Institute, 2005). Pain severity was measured using a 010 rating scale. Patients are asked to rate, on a scale of 0 to 10, how much pain they are
currently in. Scoring is as follows: 0=no pain, 1-3=mild pain, 4-6=moderate pain, 710=severe pain (Jones, Vojir, Hutt, & Fink, 2007).
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Mental Health Comorbidities
Information regarding the symptom severity of a mental health comorbid
condition typically experienced along with PTSD (e.g., depression) was assessed through
medical chart reviews. Specifically, provider’s progress notes often include, as
appropriate, scores on several clinical measures of mental health issues. The assessment
scores most commonly utilized among VA providers for depression, where available,
were recorded for each patient: Depression severity, most commonly assessed among VA
providers using the PHQ-9, was recorded when available. The PHQ-9 is a 9-item
measure used to assess depression severity. Patients are asked to think about the last 2
weeks, and report how much they were bothered by the problems inquired about in the
questions. Response options are on a 4 point scale, and include 0 (not at all), 1 (several
days), 2 (more than half the days), 3 (nearly every day). Scores are added together for a
total depression severity score (University of Michigan Health System (UMHS), 2011).
PTSD Symptoms
Symptom endorsement was assessed using the revised DSM-V diagnostic
criterion; patient’s progress notes were scanned for mention of or diagnostic assessments
of PTSD symptoms that the patient is experiencing. Symptom clusters and individual
symptoms were recorded. PTSD symptom severity was assessed using the PTSD
Checklist (PCL) (see Appendix C); PCL scores were also be extracted from patient’s
medical records, where available. The PCL is a 17-item measure which asks patients
about their experiences with PTSD symptoms; response options are on a 5-point scale,
and range from 1 (not at all) to 5 (extremely). PCL scores range from 17-85, with PTSD
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severity levels classified as follows: <40 indicates non-significant symptoms, 40-50
indicates moderate symptoms, and >50 indicates severe symptoms. A change of at least 5
points on the PCL indicate response to treatment, and a change of at least 10 points
indicates a clinically significant improvement (National Center for PTSD, 2012).
Self-Reported Health Status
A self-report measure of health status was included with the CEPEP survey; the
Veterans RAND 12-Item Health Survey (VR-12) is a validated, reliable measure of
health status. The VR-12 produces two summary scores: mental health and physiological
health. The scale consists of 12 questions, and is scored based on guidelines provided by
the scale’s developers; higher scores indicate better health status (Kazis, Selim, Rogers,
Ren, Lee, & Miller, 2006). Self-reported health status was compared in the sub-set of
patients for whom CEPEP survey data were available.
Perceptions of Patient-Centered Care Constructs
The integrative mental health treatment model is geared toward ensuring the
delivery of patient-centered care, and as such, this study assessed patient perceptions of
several important patient-centered care constructs, as collected via the CEPEP survey
(see Appendix D), in a sub-set of patients for whom CEPEP survey data were available.
Patient-centered care constructs measured included:
Global Practice Experience (GPE). Designed for the evaluation of the PatientCentered Medical Home National Demonstration Project, the GPE is a 2 question scale
which provides an all-or-nothing rating of patient’s satisfaction with their experience at
their health care facility (Jaen et al., 2010; Nutting et al., 2010), and is based on Institute
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of Medicine criteria (IOM, 2001). Questions are: ‘I receive exactly the care I want and
need when and how I want and need it’ and ‘I am delighted with this practice’. Response
options range from ‘strongly disagree’ to ‘strongly agree’; scores provided are the
proportion of patients who provide a ‘full successful’ rating, which is given only when
the patient provides a ‘strongly agree’ response to both questions.
Consultation and Relational Empathy (CARE). The CARE is a valid and
reliable 10-item scale that assesses patient’s perceptions of provider’s empathy and
patient-provider communication (Mercer, & Reynolds, 2002; Mercer, Maxwell, Heaney,
& Watt, 2004). While the original CARE measure’s questions referred to a specific
consultation, we adapted the wording such that questions better fit the experience of care
in the VA, altering ‘consultation’ to ‘visit’ or ‘clinical encounter.’ Questions include:
How was the provider at. . . ‘making you feel at ease?’, ‘…letting you tell your “story?”’,
‘…making a plan of action with you?’ Response options are on a 5 point scale, and range
from 1 (poor) to 5 (does not apply); each question also has a ‘does not apply’ option
available. Scores are added, and range from 10 to 50; the scale may still be scores with up
to 2 ‘does not apply’ or missing values. Higher scores reflect higher perceptions of
provider empathy and patent-provider communication.
Patient Activation Measure (PAM). The PAM (Hibbard, & Mahoney, 2005) is a
13-item valid and reliable instrument that measures patients’ engagement in their health
care. Using a 4-point scale (response options ranging from ‘strongly disagree’ to
‘strongly agree’), patients are asked to rate their level of agreement with statements
reflecting the stages of activation, which represent a 4-stage developmental process of
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activation. Responses are added, and using a conversion table designed by the scale’s
developers, those raw scores are converted into an overall patient activation score, which
ranges from 0-100 (if there are missing responses, take the mean of the answers provided
and multiply by 13 prior to concerting the scores). Patient activation scores are also
classified into stages of activation (1=believing that an active patient role is important;
2=having the confidence and knowledge to take action; 3=taking action; 4=staying the
course under stress); higher scores and higher stages of activation represent greater
patient activation/engagement in their care.
Press-Ganey Questions. The 5 Press-Ganey questions assess family involvement
in care, respect for choices, and support. Response options are presented on a 5 point
scale, and range from 1 (very poor) to 5 (very good). Scores are summed, and raw scores
are converted to a 0-100 point scale (Tackett, Tad-y, Rios, Kisuule, & Wright, 2013);
higher scores indicate better outcomes.
Patient Assessment of Chronic Illness Care (PACIC). The PACIC is a valid,
reliable instruments used to assess patient perceptions of the extent to which their health
care is aligned with the chronic care model (Glasgow, Wagner, Schaefer, Mahoney, Reid,
& Greene, 2005). The PACIC is comprised of 20 questions, which provide scores
concordant with 5 sub-scales: patient activation (how much patient engagement is
sought), delivery system design (how much information is provided to patients to aid in
decision-making); goal setting/tailoring (how much patients were able to set health care
goals with their providers); problem-solving/contextual (how much patient’s life
circumstances are considered when forming treatment plans); follow-up/coordination
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(care management and at-home follow-up). Questions ask that the patient to rate their
care over the past 6 months, and are rated on a 5 point scale (1=no/never to
5=yes/always). An overall mean is provided, along with mean scores for each sub-scale;
higher scores indicate greater patient perceptions of care alignment with the chronic care
model.
Combined Outcome Measure for Risk Communication and Treatment
Decision Making Effectiveness (COMRADE)
The COMRADE is a valid, reliable 20-item measure of patient’s perceptions of
how much they are involved in the decision-making process when it comes to their care
(e.g., shared decision-making) (Edwards et al., 2003). The scale provides scores for two
sub-scales, which reflect the key elements of shared decision-making: risk
communication (how well the benefits and risks of treatment options are communicated
to the patient) and decision making effectiveness (how much patients are able to
participate in making decisions about their treatment). Response options are presented on
a 5 point scale, and range from 1 (strongly disagree) to 6 (strongly agree). Scores for the
2 sub-scales are calculated based on an algorithm provided by the scale’s developers, and
range from 0-100; higher scores represent greater patient perceptions of shared decisionmaking.
Provider Recommendations for Treatment
Data on provider’s treatment recommendations (e.g., psychotherapy,
pharmacology, CAM) were extracted from patient’s progress notes.
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Patient Preferences for Treatment
Assessment of patient preferences for treatment were made based on a
comprehensive assessment of the content of progress notes across the course of
treatment; an example of a patient preferences is if a patient tells their provider that they
do not wish to participate in pharmacological treatment because they medication they are
on gives them side-effects; the provider may either accommodate the patient’s preference
(e.g., recommend an alternative, non-pharmacological treatment option) or recommend
treatment that is not concordant with what the patient wants (e.g., insist the patient stays
the course of the medication).
Statistical Analyses
Bivariate Comparisons
To assess differences among Veterans with PTSD receiving IMH care to those
receiving usual care, bivariate analyses were conducted for all variables (student’s t-tests
were used in instances where the dependent variable was continuous, and chi-square tests
in instances where the dependent variable was categorical) by group membership.
Student’s t-tests assess the magnitude of the mean difference of a given variable between
members of two independent groups; chi-square tests assess whether the proportion of
individuals who fall into various categories of a given outcome variable are statistically
significant across levels of an independent variable. Additionally, in cases where
continuous outcome variables could be sensibly grouped together (e.g., select patientcentered care, mental health care utilization, general health care utilization measures),
Hotelling’s T2 tests were conducted in an effort to increase power.
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For all bivariate comparisons, patients in the two groups were compared on all
demographic variables to highlight similarities and potential differences among groups;
variables that showed significant differences were included in the multivariate logistic
regression analysis as covariates, to control for potential confounding effects of those
potential differences among groups on outcomes of interest.
Competing regression models were built based on significant bivariate
associations, as well as commonly modeled variables as seen in the literature
(significance will be based off of p < .05). Variables which produced significant chisquare statistics were included in the model first. Consequently, individual variables that
did not yield significant bivariate associations, but are typically included in such analyses
for the population at hand, were also added to the model to create competing models.
Multicolinearity among independent variables was assessed.
Multivariate Logistic Regression Analyses
To assess patient-centered care variables associated with receipt of integrative
mental health care, a multivariate logistic regression was conducted. Logistic regression
analysis is predominantly used to predict outcomes for a categorical dependent variable,
from a set of multiple independent variables that can be continuous or categorical
(Tabachnick & Fidell, 2007). Since the outcome variable in the current study is a
dichotomous, categorical variable (type of mental health service received - integrative
mental health care vs. usual care) and a group of predictor variables (both categorical and
continuous variables), binary logistic regression was the best-suited analysis. Further, as
the outcome variable is dichotomous and no a-priori hypotheses concerning the order of
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importance of the predictor variables was established, a direct (as opposed to stepwise or
sequential) logistic regression analysis was used (Tabachnick & Fidell, 2007).
Logistic regression analysis is based on the following assumptions: the
relationship between continuous predictor variables and the transformed dependent
variable is linear; independence of responses; adequate sample size to predictor variables
ratio; adequate cell-frequencies for each independent variable included in the model (as
well as the dependent variable); no outliers present in the data; that multicolinearity is not
a problem pertaining to the group of independent variables (Tabachnick & Fidell, 2007).
Predictive utility of variables was assessed using the Wald chi-square statistic
(Mendenhall & Sincich, 2011). In order to assess the fit of the regression model, the final
model was compared to a null model (which does not include any predictor variables)
(Tabachnick & Fidell, 2007). By subtracting the Log-likelihood (-2LL) value of the final
model from that of the null model, a chi-square value assessing goodness of fit was
obtained. The significance of this chi-square value is based on the number of predictor
variables in the null model (1) minus the number of predictor variables in the model
including the group of predictors (Tabachnick & Fidell, 2007). If the final model yields a
significant log-likelihood chi-square difference, the model increases the ability to predict
the likelihood of each independent variable based on integrative mental health treatment
receipt (Tabachnick & Fidell, 2007).
The logistic regression model provides odds ratios and 95% confidence intervals
for each individual predictor variable. Odds-ratio values which exceed 1.0 are associated
with increased odds of that variable for Veterans who received integrative mental health
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treatment, and those which were less than 1.0 will be associated with decreased odds of
that variable for Veterans who received integrative mental health treatment (Peng, Lee &
Ingersoll, 2002). The analysis also generated 95% confidence intervals around the odds
ratios; for each predictor variable, we can say with 95% confidence that the true
population increase/decrease in the likelihood of that variable for Veterans who received
integrative mental health treatment falls between the interval values.
Mediation Analyses
According to Baron and Kenny (1986), four relationships are necessary in order
for mediation to be established. First, an association between the predictor variable and
the outcome variable must be established [Path C]. Next, a relationship between the
predictor variable and the mediating variable must be established [Path A]. Third, a
relationship between the mediating variable and the outcome variable must be established
[Path B] (Baron & Kenny, 1986). Once the first three paths are established, mediation is
tested for. In order for any level of mediation to exist, the relationship between the
mediator and the outcome variable must remain significant when the predictor variable is
being controlled for. The mediating relationship is considered ‘full’ if, when the mediator
is entered into the model, the predictor variable is no longer significant; alternatively, the
mediating relationship is considered ‘partial’ if both the predictor and mediator are
significant in the multiple regression model (Baron & Kenny, 1986).
For the current study, the hypothesis that the relationship between type of mental
health treatment received (integrative mental health vs. usual mental health care) and
receipt of adequate mental health treatment (9 or more mental health visit in the year
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following treatment initiation) is mediated by patient perceptions of important patientcentered care constructs (shared decision-making; patient activation) known to be
associated with health services utilization, including mental health care services, was
testing was tested using Hayes’ (2012) PROCESS Macro for SPSS (specifically, using
the Model 4 template), which uses a bootstrapping approach to create confidence
intervals for the indirect effects. Two meditational models were conducted; the
established models consisted of the following variables: (1) group membership
(integrative mental health vs. usual mental health care services received; predictor
variable), patient perceptions of patient activation (mediator), and receipt of ‘adequate’
mental health services (outcome variable), and; (2) group membership (integrative mental
health vs. usual mental health care services received; predictor variable), patient
perceptions of shared decision-making (mediator), and receipt of ‘adequate’ mental
health services (outcome variable).
Moderated Mediation Analyses
In some cases, a meditational effect can be present only for (or stronger in) one
group/type of people vs. another; this type of relationship is referred to a moderated
mediation. For the present study, moderated mediation was tested using Hayes’ (2012)
PROCESS Macro for SPSS, which uses a bootstrapping approach to create confidence
intervals for the indirect effects. Specifically, using the Model 14 template (please see
Figure 1), the possibility that patient perceptions of shared decision-making mediate the
relationship between receipt of IMH services and receipt of adequate mental health care
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for PTSD only for patients with high patient activation (whereas no mediating
relationship exists for those with low patient activation) was tested.
Figure 1. Model 14 (Preacher, 2012)
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CHAPTER SEVEN
RESULTS
As a disclaimer, prior to presenting the study results we would like to mention
that while we realize the family-wise error issue present in this study, because the present
research is somewhat exploratory we are using .05 as our type I error rate (e.g., to
determine statistical significance). However, we will also be reporting results with pvalues less than .1, so as to avoid missing detection of possible benefits of the IMH
program. Such findings, however, should not be considered reliable without further
replication(s), with data sets providing greater statistical power.
Power Analyses
Post-hoc power analyses were conducted to assess power associated with the
administrative and survey data available for this project. Power analyses were conducted
for variables with the lowest and highest effect sized (to establish the range of power for
each data collection method) based on the procedure outlined by Cohen (1988): effect
sizes were determined based on the results of the bivariate analyses, and in combination
with the respective sample sizes, were used to determine power from look-up tables
(Cohen, 1988).
Administrative Data
Of the variables compared between Veterans with PTSD who received IMH vs.
UMH treatment using administrative data, power ranged from <26% - 94%. The variable
67
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producing the lowest effect size (and thusly, the lowest power) was visits associated with
suicide/self-injury (Cohen’s D=0.00; power=<26%), while prescription fills of
psychotropic medications resulted in the highest power (Cohen’s D=0.28; power-94%).
The high end of the range of power detected for the administrative data analyses was
considered adequate (>80%), however, differences for some administrative data variables
examined may be undetectable based on low power. Additionally, administrative data
were collected for a sample of 234 Veterans; based on critical values, minimum
necessary effect sizes to detect significant differences are: 0.13 for a chi-square test with
1 degree of freedom, 0.16 for a chi-square test with 2 degrees of freedom, and 0.22 for a
t-test.
Survey Data
Of the variables compared between Veterans with PTSD who received IMH vs.
UMH treatment using survey data, power ranged from <12%->99.5%. The variable
producing the lowest effect size (and thusly, the lowest power) was patient’s perceptions
of their overall health care experience, as measured by the Global Practice Experience
measure (effect size=0.01, power=<12%), while patient activation (Cohen’s D=-2.57,
power=>99.5%) and shared-decision making (Cohen’s D=-0.49, power=81%) resulted in
the highest power. The high end of the range of power detected for the survey data
analyses surpassed the threshold for what is considered adequate power (>80%),
however, differences for some survey variables examined may be undetectable based on
low power. Additionally, survey data were collected for a sample of 61 Veterans; based
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on critical values, minimum necessary effect sizes to detect significant differences are:
0.25 for a chi-square test with 1 degree of freedom, and 0.44 for a t-test.
Chart Review Data
The chart review sample for the present study was determined based on an apriori power analysis. As a general rule, literature suggests that between 5 and 10 charts
per variable of interest is the rule of thumb for deciding a chart review sample size
(Gearing, Mian, Barber, & Ickowicz, 2006). Technically, 6 variables are being obtained
from the chart review data collection piece of this project: pain severity, depression
severity, PTSD symptom endorsement, PTSD symptom severity, provider’s treatment
recommendations & discussion of patient’s preferences for treatment. However, since
symptom endorsement was examined separately for all 4 PTSD symptom clusters, the
‘symptom endorsement’ variable is being considered as 4 separate variables.
Accordingly, conducting chart reviews for 90 individuals provides sufficient power for
the chart review data collection efforts of this project. Additionally, chart review data
were collected for a sample of 90 Veterans; based on critical values, minimum necessary
effect sizes to detect significant differences are: 0.21 for a chi-square test with 1 degree of
freedom, 0.26 for a chi-square test with 2 degrees of freedom, and 0.35 for a t-test.
Reliability: Scales Used to Measure PCC
For measurement scales for which we had item-level data (e.g., scales used to
measure patient perceptions of PCC), we calculated the reliability among our sample
(e.g., the Cohen’s α statistic) for each scale. All of the PCC scales were found to be
highly reliable among our sample: (1) GPE, α =0.92; (2) CARE, α =0.99; (3) PAM, α
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=0.91; (4) Press-Ganey questions, α =0.94; (5) PACIC, α =0.97; (6) VR-12, overall, α
=0.87; VR-12, PCS, α =0.83; VR-12, MCS, α =0.74; (7) COMRADE, overall, α =0.98;
COMRADE, RC, α =0.97; COMRADE, DME, α =0.90.
Bivariate Comparisons
Demographics, Chronic Health Conditions, and Comorbid Mental Health Diagnoses
At baseline, Veterans comprising the IMH and UMH groups were extremely
similar, with no significant differences noted across any demographic, chronic condition,
or comorbid mental health condition diagnoses (see Table 2 below). There were a
marginally greater proportion of men and individuals with bipolar disorder in the UMH
group compared to the IMH group, however no statistically significant differences in
demographics, physical or mental health conditions existed between Veterans comprising
the IMH vs. UMH groups.
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Table 2. Demographics, chronic conditions and comorbid mental health diagnoses for
Veterans with PTSD who received IMH vs. usual mental health care (n=234)
Overall
Usual
IMH
pt- or
df Effect
%
Care
(n=117)
value chi-sq
Size*
(n=234)
(n=117)
value
Demographics
Male Gender
89.74
93.16
86.32
0.08
2.97
1
0.11
(n=234)
Age (n=234)
49.56
49.35
49.78
0.83
-0.21 232 -0.03
[Mean (range) SD]
(21.90(21.90(22.5187.43)
87.43)
78.11)
15.55
16.09
15.05
Race (n=205)
0.13
4.02
2
0.14
White
62.93
67.65
58.25
Black
28.78
22.55
34.95
3
Other
8.29
9.80
6.80
Ethnicity1 (n=219)
13.70
13.64
13.76
0.98
0.001
1
0.002
2
Married (n=233)
57.51
52.59
62.39
0.13
2.29
1
0.10
Service-Connected
0.44
1.64
2
0.08
Disability %
(n=234)
0%
21.79
24.79
18.80
1%-49%
23.08
20.51
25.64
50%-100%
55.13
54.70
55.56
Select Chronic Conditions
(n=234)
Heart Disease
28.21
28.21
28.21
1.00
0.00
1
0.00
Cancer
9.83
7.69
11.97
0.27
1.21
1
0.07
Chronic Lower
20.94
23.08
18.80
0.42
0.65
1
0.05
Respiratory
Disease
Stroke
5.98
5.98
5.98
1.00
0.00
1
0.00
Diabetes
24.79
24.79
24.79
1.00
0.00
1
0.00
Number of chronic
0.90
0.90
0.90
1.00
0.00
232
0.00
conditions3 (count)
(0.00(0.00(0.00[Mean (range) SD]
4.00)
4.00)
4.00)
0.99
0.98
1.01
4
Multimorbidity
24.36
26.50
22.22
0.45
0.58
1
0.05
Select Mental Health
Conditions (n=234)
History of military
9.40
8.55
10.26
0.65
0.20
1
0.03
sexual trauma
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Adjustment
8.97
9.40
8.55
0.82
0.05
1
0.01
disorders
Anxiety disorders
43.16
41.88
44.44
0.69
0.16
1
0.03
Impulse control
1.71
1.71
1.71
1.00
0.001
1
0.002
disorders NEC
(including
pathological
gambling)
Bipolar disorders
8.12
11.11
5.13
0.09
2.81
1
0.11
Depressive
67.95
63.25
72.65
0.12
2.37
1
0.10
disorders
Personality
3.42
4.27
2.56
0.47
0.52
1
0.05
disorders
Schizophrenia &
3.85
4.27
3.42
0.73
0.12
1
0.02
other psychotic
disorders
Substance use
20.09
19.66
20.51
0.87
0.03
1
0.01
disorders (alcohol
and substancerelated disorders)
Suicide &
3.42
4.27
2.56
0.47
0.52
1
0.05
intentional selfinflicted injury
1
Hispanic ethnicity presented
2
Reference group: Not Married
3
Of the following chronic conditions: heart disease, cancer, chronic lower respiratory
disease, stroke, diabetes
4
Defined as having ≥2 of the following chronic conditions: heart disease, cancer, chronic
lower respiratory disease, stroke, diabetes
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical
variables
Health Care Utilization
Health care utilization variables were examine in the year following treatment
initiation, and compared across UMH and IMH groups (see Table 3). As hypothesized, in
regard to mental health care utilization, Veterans in the UMH group averaged
significantly more prescription psychotropic medication fills in the year following
treatment initiation than those in the IMH group. Contrary to hypotheses, no other
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differences in ‘appropriate’ mental health utilization were observed between the UMH
and IMH groups. While no statistically significant differences were observed in the
proportion of Veterans who received adequate mental health care services between those
who received IMH vs. UMH services, descriptively 22% of those in the IMH group
received adequate mental health services, compared to about 18% of those in the UMH
group.
Further, Hotelling’s T2 test examining differences in mental health utilization
variables (outpatient visits related to mental health services, prescription psychotropic
medication fills) between IMH and UMH groups simultaneously revealed marginally
significant mean differences, Hotelling’s T2=5.34, F(2,231)=2.66, p=0.07, Mahalinobis
Distance=0.30. (In order to reach significance, a Mahalinobis Distance of 0.36 is needed).
These results corroborate that, overall, IMH services may catalyze change in mental
health care utilization.
In terms of general health services use, as hypothesized, Veterans in the UMH
group averaged a marginally lesser number of outpatient visits and specifically, primary
care visits in the year following treatment initiation then those in the IMH group,
indicating that IMH services may foster ‘appropriate’ health care utilization among
Veterans with PTSD.
Hotelling’s T2 tests examining differences in general health care utilization
variables (outpatient visits, ER visits, prescription medication fills) between IMH and
UMH groups simultaneously, however, did not reveal significant mean differences,
Hotelling’s T2=5.11, F(3,230)=1.69, p=0.17, Mahalinobis Distance=0.30. (In order to
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reach significance, a Mahalinobis Distance of 0.36 is needed). These results indicate that,
while receipt of IMH services may impact outpatient health care utilization, overall,
receipt of these services may not impact general health care utilization trends when health
care use is considered all together.
Table 3. Health services utilization among Veterans with PTSD who received IMH vs.
usual mental health care (n=234)
Overall %
Usual
IMH
pt- or
df Effect
(n=234)
Care
(n=117)
value chi-sq
Size*
(n=117)
value
Mental Health Services Utilization (n=234)
Adequate mental
20.09
17.95
22.22
0.41
0.67
1
0.05
health care
utilization1 (%)
Outpatient visits
5.64
4.89
6.38
0.18
-1.35
232 -0.18
related to mental
(0.00(0.00(0.00health services
57.00)
43.00)
57.00)
[Mean (range) SD] 8.51
7.52
9.37
Prescription
4.12
4.86
3.37
2.10
232 0.27
0.04
psychotropic
(0.00(0.00(0.00medication fills
27.00)
27.00)
25.00)
[Mean (range) SD] 5.49
6.22
4.56
Visits Associated With Select Mental Health Conditions (n=234) [Mean (range)
SD]
Adjustment 0.11
0.14
0.08
0.46
0.73
232 0.10
disorders (0.00(0.00(0.007.00)
7.00)
4.00)
0.62
0.74
0.48
Anxiety disorders 0.62
0.61
0.62
0.94
-0.07
232 -0.01
(0.00(0.00(0.0013.00)
13.00)
9.00)
1.75
2.00
1.46
PTSD 8.39
7.96
8.83
0.45
-0.76
232 -0.10
(0.00(0.00(0.0047.00)
38.00)
47.00)
8.82
8.13
9.48
Impulse control 0.01
0.01
0.02
0.56
-0.58
232 -0.11
disorders NEC (0.00(0.00(0.00(including 1.00)
1.00)
1.00)
pathological 0.11
0.09
0.09
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gambling)
Bipolar disorders 0.11
0.18
(0.00(0.007.00)
7.00)
0.67
0.88
Depressive 1.53
1.69
disorders (0.00(0.0018.00)
18.00)
3.08
3.63
Personality 0.01
0.03
disorders (0.00(0.003.00)
3.00)
0.20
0.28
Schizophrenia & 0.03
0.05
other psychotic (0.00(0.00disorders 4.00)
4.00)
0.30
0.41
Substance use 0.26
0.16
disorders (alcohol (0.00(0.00and substance- 31.00)
15.00)
related disorders) 2.35
1.43
Suicide & 0.00
0.00
intentional self- (0.00(0.00inflicted injury 0.00)
0.00)
0.00
0.00
General Health Services Utilization (n=234)
Inpatient
0.07
0.04
discharges [Mean
(0.00(0.00(range) SD]
6.00)
1.00)
0.47
0.20
Length of Stay 0.50
0.24
[Mean (range) SD] (0.00(0.0042.00)
16.00)
3.57
1.64
Outpatient visits
12.13
10.48
[Mean (range) SD] (0.00(0.0068.00)
68.00)
14.28
12.98
Primary care visits 1.50
1.26
[Mean (range) SD] (0.00(0.0013.00)
9.00)
1.94
1.66
ER visits
0.24
0.27

0.04
(0.004.00)
0.38
1.38
(0.0016.00)
2.41
0.00
(0.000.00)
0.00
0.01
(0.001.00)
0.09
0.35
(0.0031.00)
3.00
0.00
(0.000.00)
0.00

0.12

1.56

232

0.21

0.43

0.79

232

0.10

0.32

1.00

232

0.15

0.27

1.09

232

0.13

0.54

-0.61

232

-0.08

--

--

232

0.00

0.10
(0.006.00)
0.64
0.74
(0.0042.00)
4.77
13.78
(0.0061.00)
15.36
1.74
(0.0013.00)
2.16
0.22

0.33

-0.97

232

-0.13

0.29

-1.06

232

-0.14

0.08

-1.77

232

-0.23

0.06

-1.90

232

-0.25

0.61

0.51

232

0.08
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[Mean (range) SD]

(0.00-4.00 (0.00(0.000.64
4.00)
3.00)
0.66
0.62
Prescription
16.19
17.03
15.36
0.53
0.64
232 0.08
medication fills
(0.00(0.00(0.00(general)
95.00)
80.00)
95.00)
[Mean (range) SD] 20.00
19.62
20.43
1
9 or more mental health treatment visits within 12 months of the patient’s index
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical
variables
Physical Health
Contrary to hypotheses, IMH and UMH groups did not differ on any of the proxy
measures of physical health (visits with poor health indicators, self-reported physical
health (VR-12) scores) (see Table 4). However, descriptively, average self-reported
physical health scores were higher among Veterans in the IMH group compared to the
UMH group (as hypothesized), though not significantly so. Overall, 87 Veterans had 1
recorded pain score and 67 had multiple records of reported pain severity. When
comparing Veterans who received IMH to those who received UMH, there were no
differences in initially reported pain severity (3.80 vs. 3.33, p=0.4979); further, for those
who had multiple recorded pain scores there were no differences in patient’s last recorded
pain score (3.38 vs. 3.18, p=0.8092) and, contrary to hypotheses, no differences in the
amount of change in pain among the two Veteran groups.
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Table 4. Physical health indicators among Veterans with PTSD who received IMH vs.
usual mental health care (n=234)
Overall %
IMH
Usual Care
pt- or df Effect
(n=234)
(n=117)
(n=117)
value chi-sq
Size
value
***
1
Hypertension
29.49
33.33
25.64
0.20
1.66
1 0.08
(n=234)
Diabetes2 (n=234) 3.85
3.42
4.27
0.73
0.12
1 0.02
Hyperlipidemia3
16.67
18.80
14.53
0.38
0.77
1 0.06
(n=234)
VR-12: PCS
32.05
35.00
29.28
0.07
-1.82 5 0.47
*
(n=60)
(7.01(7.01(11.688
[mean (range) SD] 59.90)
59.90)
55.06)
12.41
13.12
11.21
Change in Pain
0.54
0.93
0.24
0.46
-0.74 6 0.18
Severity (n=67)** (-7.00(-7.00(-7.005
[mean (range) SD] 10.00)
8.00)
10.00)
3.77
3.88
3.70
1
Blood pressure: diastolic blood pressure ≥ 90 and systolic blood pressure ≥ 140 indicates
poor disease control; the number of visits where an indication of poor condition
management was recoded is presented for each time period
2
Hemoglobin A1C: HbA1c ≥9 indicates poor disease management; the number of visits
where an indication of poor condition management was recoded is presented for each
time period
3
Low Density Lipids (LDL): LDL ≥ 130 indicates poor disease control; the number of
visits where an indication of poor condition management was recoded is presented for
each time period
*Obtained via CEPEP survey
**Obtained via medical chart review abstraction
***Effect size measures reflect Cohen’s D for continuous variables and Phi for
categorical variables
Depression Symptom Severity, and Self-Reported Mental Health Scores
Contrary to hypotheses, there were no significant differences in self-reported
mental health scores between Veterans in the IMH group compared to the UMH group
(see Table 5). Overall, 29 Veterans had 1 recorded PHQ-9 score, and 9 had multiple
records of reported depression severity. When comparing Veterans who received IMH to
those who received UMH, there were no differences in initially reported depression
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severity (16.69 vs. 14.56, p=0.4145); further, for those who had multiple recorded
depression scores there were no differences in patient’s last recorded depression score
(17.60 vs. 14.75, p=0.6149) and, contrary to hypotheses, no differences in the amount of
change in depression among the two Veteran groups.
Table 5. Self-reported mental health status and depression severity among Veterans with
PTSD who received IMH vs. usual mental health care (n=61)
Overall %
Usual
IMH
pt- or
df
Effect
(n=61)
Care
(n=30)
value chiSize***
(n=31)
sq
value
VR-12: MCS
37.53
35.86
39.31
0.30 -1.04 58
-0.27
(n=60)*
(15.06(15.06(17.80[mean (range) SD]
63.38)
63.38)
59.72)
12.91
13.04
12.76
Change in
0.56
-0.20
1.50
0.57
0.60
7
-0.43
Depression
(-7.00(-7.00(-1.00Severity; PHQ-9
7.00)
7.00)
4.00)
Score (n=9)**
4.03
5.26
2.08
[Mean (range) SD]
*Obtained via CEPEP survey
**Obtained via medical chart review abstraction
***Effect size measures reflect Cohen’s D for continuous variables and Phi for
categorical variables
PTSD Symptom Endorsement and Symptom Severity
Overall, 39 Veterans had 1 recorded PCL score, and 16 had multiple records of
reported PTSD symptom severity. When comparing Veterans who received IMH to those
who received UMH (please see Table 6), there were no differences in initially reported
PTSD symptom severity or last recorded PCL score (51.43 vs. 60.78, p=0.1957); contrary
to hypotheses, there were no differences in the amount of change in PTSD symptom
severity among the two Veteran groups. Contrary to what we expected, however, visitlevel data indicates that a greater proportion of Veterans receiving IMH (vs. UMH)
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reported experiencing intrusion symptoms, and symptoms related to alterations in arousal
and reactivity, during primary care or mental health encounters with VA providers.
Table 6. PTSD symptom endorsement and severity among Veterans with PTSD who
received IMH vs. usual mental health care (n=90)
Overall
Usual
IMH
pt- or
df Effect
% (n=90)
Care
(n=45)
value
chiSize*
(n=45)
sq
value
Symptom Severity
At least 1 PCL score
43.33
46.67
40.00
0.52
0.41
1
0.07
documented %
(n=90)
Initial PCL Score
60.28
57.81
63.17
0.24
-1.20 37 -0.39
[Mean (range) SD] (24.00(24.00(43.00(n=39)
83.00)
74.00)
83.00)
13.93
16.38
10.08
Multiple PCL scores
17.78
20.00
15.56
0.58
0.30
1
0.06
documented %
(n=90)
Change in PCL
10.75
7.67
14.71
0.24
-1.23 14 -0.59
Score [Mean (range) (-5.00(-3.00(-5.00SD] (n=16)
34.00)
19.00)
34.00)
11.58
7.28
15.24
Change in PCL
0.88
0.25
2
0.05
Score % (n=39)
Only 1 Documented
71.79
71.43
72.22
Score (%)
Treatment
7.69
9.52
5.56
Responsive
Improvement in PCL
Score (%)
Clinically Significant
20.51
19.05
22.22
Improvement in PCL
Score (%)
Symptom
Endorsement (%)
(n=2799)
Intrusion Symptoms
5.82
2
0.05
0.05
Symptom(s) present
15.18
14.68
15.76
Not Mentioned
84.03
84.17
83.86
No symptoms
0.79
1.15
0.38
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Avoidance
0.14
3.96
2
0.04
Symptoms
Symptom(s) present
7.72
8.25
7.12
Not Mentioned
91.46
90.66
92.35
No symptoms
0.82
1.08
0.53
Negative Alterations
0.14
3.92
2
0.04
in Cognitions and
Mood Symptoms
Symptom(s) present
6.43
6.22
6.67
Not Mentioned
93.18
93.17
93.18
No symptoms
0.39
0.61
0.15
Alterations in
2
0.07
0.001 13.39
Arousal and
Reactivity
Symptoms
Symptom(s) present
21.22
19.42
23.26
Not Mentioned
78.21
79.63
76.59
No symptoms
0.57
0.95
0.15
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical
variables
Patient Perceptions of Patient-Centered Care Constructs (Table 7)
In line with hypotheses, patient perceptions of patient activation and the decisionmaking effectiveness component of shared decision-making were marginally lower, on
average, among Veterans receiving UMH compared to those receiving IMH (see Table
7). Additionally, a greater proportion of Veterans receiving UMH were in the lowest
stage of activation, as compared to those receiving IMH. No other differences in patient
perceptions of PCC constructs were noted across the two groups.
Hotelling’s T2 tests examining differences in patient-centered care variables
(patient activation, shared decision-making, consultation and relational empathy,
perceptions of patient activation in terms of chronic illness care delivery, perceptions of
family involvement in care, respect for choices, and support) between IMH and UMH
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groups simultaneously, however, did not reveal significant mean differences, Hotelling’s
T2=8.63, F(6,39)=1.27, p=0.29, Mahalinobis Distance=0.87. (In order to reach
significance, a Mahalinobis Distance of 1.08 is needed). These results indicate that, while
receipt of IMH services may impact patient’s perceptions of shared decision-making and
patient reported engagement in their health care (i.e., patient activation), overall, receipt
of these services may not impact general trends in patient’s perceptions of the patientcenteredness of their health care, when patient-centered care variables are considered all
together.
Table 7. Perceptions of patient-centered care among Veterans with PTSD who received
IMH vs. usual mental health care (n=61)
Overall Usual Care
IMH
pt- or df Effect
%
(n=31)
(n=30)
value chiSize*
(n=61)
sq
value
Patient Perceptions of Patient-Centered Care Constructs
PAM (n=57)
56.37
51.18
61.74
0.08
-1.81 55 -2.57
[mean (range) SD]
(0.00(0.00(0.00100.00) 100.00)
100.00)
22.44
4.20
4.03
PAM Stages (n=57)
44.83
17.86
4.80 1
0.29
Stage 1 (%) 31.58
0.03
13.79
10.71
0.72
0.13 1
0.05
Stage 2 (%) 12.28
24.56
17.24
32.14
0.19
1.71
1
0.17
Stage 3 (%)
24.14
39.29
0.22
1.51 1
0.16
Stage 4 (%) 31.58
COMRADE
53.78
59.03
0.34
-0.96 49 -0.27
Risk Communication 56.46
(n=51) (13.48- (13.48(21.82[mean (range) SD] 86.97) 86.97)
80.76)
19.56
21.06
18.04
54.69
64.39
0.09
-1.75 49 -0.49
Decision-Making 59.63
Effectiveness (n=51) (19.56- (19.56(20.73[mean (range) SD] 86.14) 81.14)
80.31)
20.17
23.75
14.98
CARE (n=59)
37.58
36.15
39.07
0.40
-0.85 57 -0.22
[mean (range) SD]
(10.00- (10.00(10.00-

82

PACIC (n=58)
[mean (range) SD]

Patient Activation
(n=58)

Delivery Systems
Design (n=58)

Goal
Setting/Tailoring
(n=58)
Problem
Solving/Contextual
Counseling (n=58)
Follow-Up/Care
Coordination (n=58)

Press-Ganey (n=54)
[mean (range) SD]

50.00)
13.22
3.02
(1.005.00)
1.31
3.07
(1.005.00)
1.48
3.32
(1.005.00)
1.40
3.05
(1.005.00)
1.40
3.16
(1.005.00)
1.51
2.65
(1.005.00)
1.36
2.65
(0.00100.00)
26.93

50.00)
14.01
2.91
(1.05-5.00)
1.38
3.02
(1.00-5.00)
1.62
3.16
(1.00-5.00)
1.47
2.85
(1.00-5.00)
1.47
3.03
(1.00-5.00)
1.53
2.62
(1.00-5.00)
1.43
62.93
(0.00100.00)
28.02

50.00)
12.41
3.14
(1.005.00)
1.24
3.12
(1.005.00)
1.34
3.50
(1.005.00)
1.33
3.27
(1.005.00)
1.30
3.29
(1.005.00)
1.50
2.68
(1.005.00)
1.31
69.80
(20.00100.00)
25.68

0.51

-0.67 56

-0.18

0.81

-0.25 56

-0.07

0.36

-0.92 56

-0.24

0.26

-1.14 56

-0.30

0.53

-0.63 56

-0.17

0.86

-0.18 56

-0.04

0.35

-0.93 52

-0.26

GPE (n=51)

0.94
0.01 1
0.01
25.93
25.00
Successful 25.49
74.07
75.00
Not Successful 74.51
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical
variables
Provider Recommendations for Treatment (see Table 8)
Overall, visit-level data indicates that recommendations for mental health
treatment were made during a greater proportion of IMH visits (vs. UMH visits).
Additionally, while pharmacology was recommended during a lesser proportion of IMH
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visits, CAM treatment modalities were recommended during a greater proportion of IMH
visits.
Table 8. Provider recommendations for treatment for Veterans with PTSD who received
IMH vs. usual mental health care (n=2109)
Overall
IMH
Usual
p-value t- or
df Effect
%
(n=45)
Care
chiSize*
(n=90)
(n=45)
sq
value
Provider Recommendations for Treatment
Note Included
0.11
<0.0001 33.81 1
Recommendations
for Treatment
(n=2799)
Yes
39.16
44.85
34.10
No
60.84
57.91
62.53
If yes, the
recommendation was
for: (n=1096)
Psychotherapy
80.75
80.07
81.55
0.54
0.38
1
0.02
Pharmacology
51.55
47.30
56.55
9.33
1
0.09
0.002
CAM (i.e., yoga,
7.21
9.97
3.97
0.12
0.0001 14.64 1
MBSR, etc.)
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical
variables
Patient Preferences for Treatment (see Table 9)
Visit-level data indicates that patient preferences for mental health treatment were
discussed during a greater proportion of IMH visits than UMH visits.

84
Table 9. Patient preferences for treatment among Veterans with PTSD who received IMH
vs. usual mental health care (n=2109)
Overall
Usual
IMH
pt- or
df Effect
% (n=90)
Care
(n=45)
value
chiSize*
(n=45)
sq
value
Note Included
1
0.06
0.001 10.17
Communication
about the Patient’s
Preference for Mental
Health Treatment
(n=2799) [visit-level
data]
Yes
19.22
16.98
21.74
No
80.78
83.02
78.26
Patient’s Preferences
0.84
0.34
2
0.06
for Treatment Were
Met, Overall (n=90)
[individual level
data]
Yes
84.44
82.22
86.67
No
7.78
8.89
6.67
Treatment
7.78
8.89
6.67
Preferences Not
Mentioned
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical
variables

Multivariate Logistic Regression: Factors Associated with Receipt of Integrative
Mental Health Treatment – Dependent Variable: IMH receipt [reference: UMH
receipt]
We compared a regression model consisting of patient perceptions of patientcentered care constructs which produced significant/marginally significant differences in
the bivariate comparisons in tandem with other patient-centered care constructs (as we
hypothesized that higher patient perceptions of each patient-centered construct would be
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independently associated with receiving IMH services) to a model using only predictor
variables which produced significant/marginally significant differences in the bivariate
comparisons [patient activation; shared decision-making]. Predictive utility of variables
was assessed using the Wald chi-square statistic (Mendenhall & Sincich, 2011); the
variables with significant Wald results were associated with receipt of IMH services.
In order to assess the fit of our regression model, we compared the final model to
a null model, which did not include any predictor variables (Tabachnick & Fidell, 2007).
By subtracting the Log-likelihood (-2LL) value of the final model from that of the null
model, we obtained a chi-square value assessing goodness of fit. The significance of this
chi-square value was based on the number of predictor variables in the null model (1)
minus the number of predictor variables in the model including our group of predictors
(Tabachnick & Fidell, 2007).
The first model created contained all patient-centered care constructs assessed
with the CEPEP survey. Multicolinearity was assessed using the variance inflation factor
(VIF) index; the rule of thumb for assessing multicolinerity using the VIF is as low as
values >4 - to values >10 - indicate high multicolinearity (O’Brien, 2007); none of the
patient-centered care constructs had to be removed due to mutlicolinearity. The model
containing all patient-centered care constructs produced a -2LL value of -24.46, with 7
degrees of freedom (compared to the null model produced a -2LL value of -162.20, with
1 degree of freedom), and an R-squared of 0.12. The log-likelihood difference between
this initial model and the null model was 137.7, with 6 degrees of freedom, which is a
significant chi-square value, p<.05.
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A competing model was then created, which contained only patient activation and
shared decision-making (the patient centered care constructs which were marginally
different between IMH and UMH groups in the bivariate comparisons). This model
produced a -2LL value of -31.10, with 2 degrees of freedom (compared to the null model
produced a -2LL value of -162.20, with 1 degree of freedom), and an R-squared of 0.08.
The log-likelihood difference between this initial model and the null model was 131.10,
with 1 degree of freedom, which is a significant chi-square value, p<.05.
Since both models displayed a significant increase in fit over the null model, to pit
them against one another we subtracted the -2LL values for the model containing only
patient activation and shared decision-making to the model containing all of the patientcentered care constructs; based on (7 – 2 = 5) degrees of freedom, our log-likelihood
difference of: 31.10 – 24.46 = 6.64, which is not significant at p<0.05. While this nonsignificant -2LL test indicates that both models are of relatively similar fit, the model
containing only the variables which produced significant bivariate associations was
selected this as the final model as it was the more parsimonious model.
The logistic regression model provided us with odds ratios and 95% confidence
intervals for each individual predictor variable. Odds-ratio values which exceeded 1.0
were associated with increased odds of having received an adequate amount of
information, and those which were less than 1.0 were associated with decreased odds
(Peng, Lee & Ingersoll, 2002). The analysis also generated 95% confidence intervals
around the odds ratios; for each predictor variable, we are 95% confident that the true
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population increase/decrease in the likelihood for having received IMH services falls
between the interval values.
While accounting for approximately 8% of the variance between receipt of IMH
compared to UMH treatment, the final model did not identify either of the included
patient-centered care constructs as being independently associated with receipt of IMH
services (see Table 10).
Table 10. Logistic regression analysis: patient-centered care constructs independently
associated with receipt of IMH treatment (n=49)
Odds
95% Wald
p-value
Ratio Confidence Limits
Patient Activation [PAM]
2.86
0.76
10.78
0.12
Shared Decision-Making [COMRADE]
Decision-Making Effectiveness 1.02
0.98
1.05
0.34
*R-squared: 0.08
Mediation Analyses
Patient Activation As A Mediator Between IMH vs. UMH Treatment and Receipt of
Adequate Mental Health Care
The first mediation model conducted examined whether patient activation
mediated the relationship between receipt of IMH treatment and receipt of adequate
mental health care (please see Figure 2). In this model, we examined whether group
membership (integrative mental health vs. usual mental health care services received)
predicted patient activation, whether patient activation predicted receipt of ‘adequate’
mental health services, and whether the relationship between group membership and
receipt of ‘adequate’ mental health services was significantly reduced when we
controlled for patient activation (Baron & Kenny, 1986).
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Figure 2 contains a depiction of the results from this mediational analysis. As
predicted, Veterans who received IMH treatment reported (marginally) higher levels of
patient activation (path a was marginally significant: unstandardized β=10.56, SE=5.83,
p=0.08; standardized β=0.24, SE=0.13, p=0.08). However, being a Veteran with higher
patient activation was not significantly related to receiving adequate mental health
treatment (path b was not significant, unstandardized β=0.004, SE=0.01, p=0.79;
standardized β=0.08, SE=0.31, p=0.79). Further, group membership (receipt of IMH vs.
UMH treatment) was not predictive of receiving adequate mental health care
(unstandardized β=0.19, SE=0.62, p=0.76; standardized β=0.10, SE=0.31, p=0.76).
Finally, after taking the relationship between group membership and patient activation
into account, the direct path between group membership and receipt of adequate mental
health care (path c) was (still) not significant (unstandardized β=0.19, SE=0.62, p=0.76;
standardized β=0.10, SE=0.31, p=0.76).
Despite one of the assumptions underlying mediation was not met (e.g.,
insignificant path b), we tested the significance of the indirect path (and thus tested for
mediation). The combined indirect paths (e.g. group membership to patient activation and
patient activation to receipt of adequate mental health treatment) were not significant,
unstandardized β=0.04, SE=0.20, CI95%=-0.34-0.59; standardized β=0.02, SE=0.10,
CI95%=-0.15-0.27. Therefore, results indicate that the relationship between group
membership and receipt of adequate mental health care is not mediated by patient
activation.
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Figure 2. Mediational Model: Patient Activation
Patient
Activation
A = 10.56*

B = 0.004

Group
Membership
(IMH vs.
UMH)
C’ = .04

Receipt of
‘Adequate’
MH
Treatment

[*=marginally significant at p<.10; unstandardized Betas are shown]
Shared Decision-Making As A Mediator Between IMH vs. UMH Treatment and
Receipt of Adequate Mental Health Care
The second mediation model conducted examined whether shared decision-making
mediated the relationship between receipt of IMH treatment and receipt of adequate
mental health care (please see Figure 3). In this model, we examined whether group
membership (integrative mental health vs. usual mental health care services received)
predicted shared decision-making, whether shared decision-making predicted receipt of
‘adequate’ mental health services, and whether the relationship between group
membership and receipt of ‘adequate’ mental health services was significantly reduced
when we controlled for shared decision-making (Baron & Kenny, 1986).
Figure 3 contains a depiction of the results from this mediational analysis. In this
model, we examined whether group membership (integrative mental health vs. usual
mental health care services received) predicted patient’s perceptions of shared medical
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decision-making, whether patient’s perceptions of shared medical decision-making
predicted receipt of ‘adequate’ mental health services, and whether the relationship
between group membership and receipt of ‘adequate’ mental health services was
significantly reduced when we controlled for patient’s perceptions of shared medical
decision-making (Baron & Kenny, 1986).
As predicted, Veterans who received IMH treatment reported (marginally) higher
perceptions of shared medical decision-making (path a was marginally significant:
unstandardized β=9.70, SE=5.54, p=0.09; standardized β=0.24, SE=0.14, p0.09) (Figure
4). However, being a Veteran with a higher perception of shared medical decisionmaking was not significantly related to receiving adequate mental health treatment (path
b was not significant; unstandardized β=0.01, SE=0.02 p=0.46; standardized β=0.27,
SE=0.36, p=0.46). Further, group membership (receipt of IMH vs. UMH treatment) was
not predictive of receiving adequate mental health care (unstandardized β=-0.17,
SE=0.68, p=0.81; standardized β=-0.08, SE=0.34, p=0.81). Finally, after taking the
relationship between group membership and patient’s perceptions of shared medical
decision-making into account, the direct path between group membership and receipt of
adequate mental health care (path c) was (still) not significant (unstandardized β=-0.17,
SE=0.68, p=0.81; standardized β=-0.08, SE=0.34, p=0.81).
Despite one of the assumptions underlying mediation was not met (e.g.,
insignificant path b), we tested the significance of the indirect path (and thus tested for
mediation). The combined indirect paths (e.g. group membership to perceptions of shared
medical decision-making and perceptions of shared medical decision-making to receipt of
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adequate mental health treatment) were not significant, unstandardized β=0.13, SE=0.40,
CI95%=-0.21-1.15; standardized β=0.07, SE=0.18, CI95%=-0.12-0.59. Therefore, results
indicate that the relationship between group membership and receipt of adequate mental
health care is not mediated by patient’s perceptions of shared medical decision-making.
Figure 3. Mediational Model: Shared Decision-Making

A = 9.70*

Group
Membership
(IMH vs.
UMH)

Shared
DecisionMaking

C’ = .13

B = 0.01

Receipt of
‘Adequate’
MH
Treatment

[*=marginally significant at p<.10; unstandardized Betas are shown]
Moderated Mediation Analyses
The impact of shared medical decision-making on the relationship between
treatment group and receipt of adequate mental health treatment was much larger for
Veterans with high patient activation (unstandardized β=0.4527; CI: -0.2768 - 5.8966;
standardized β=0.23, CI: -0.17 – 2.64) than those with low patient activation
(unstandardized β=0.0510; CI: -2.0974 - 1.7274; standardized β=0.03, CI: -1.20 – 0.75),
however, as neither of these effects were significant, a true difference of zero cannot be
ruled out. Additionally, the index of moderated mediation indicates that the effects of
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shared medical decision-making on the relationship between treatment group and receipt
of adequate mental health treatment do not significantly differ between Veterans with
high vs. low patient activation, however, descriptively the effects are going in the
hypothesized direction.

CHAPTER EIGHT
DISCUSSION
Collectively, the results of this project indicate that, among Veterans with PTSD
receiving VA health care, IMH treatment receipt is associated with: increased outpatient
and primary care visits; decreased psychotropic medication use; increased
recommendations for CAM treatment modalities and decreased recommendations for
pharmacological treatment; discussion of patient preferences for mental health treatment
during a greater number of VA primary care and mental health encounters; better patient
perceptions of physical health status; greater patient-reported patient activation (e.g.,
engagement in health care), and; better patient perceptions of shared medical decisionmaking. Specifically:
Health Care Utilization and Provider Recommendations for Treatment
Previous research has found that, among Veterans with mental health concerns,
mental health treatment receipt in an IMH setting may foster more appropriate health care
utilization; specifically, increased primary care and specialty medical care visits (Engel,
Malta, Davies, & Baker, 2011) and decreased preventable hospitalizations (Pirraglia,
Kilbourne, Lai, Friedmann, & O’Toole, 2011). In line with these findings, of the
Veterans with PTSD in our cohort, those who were in the IMH group had a marginally
greater number of outpatient visits in general, as well as primary care visits specifically,
in the year following treatment initiation.
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We did not, however, find differences in hospitalizations, ER visits, or overall
number of prescription medications filled between Veterans receiving IMH services as
compared to those receiving UMH treatment. Though one previous study has also failed
to observe decreases in ER use among Veterans receiving IMH treatment (Engel, Malta,
Davies, & Baker, 2011), these null findings were not entirely aligned with the literature
or hypotheses.
Further, contrary to hypotheses, we also did not find differences in the proportion
of Veterans who received adequate mental health treatment in the year following
treatment initiation, nor did we detect differences in the average number of mental health
specialty care visits or the average number of visits for any specific mental health
diagnoses (including PTSD), between our IMH and UMH groups. Similarly, one recent
study found that Veterans with PTSD who received a psychotherapy referral from a
primary care provider were less likely to initiate treatment as compared to those who
were referred from a specialty mental health provider (Keller & Tuerk, 2015). These
differences in appropriate mental health care use were expected, however, as several
other previous studies have reported improved mental health care utilization among
Veterans with mental health concerns, specifically, improved mental health care
continuation (Bohnert, Pfeiffer, Szymanski, & McCarthy, 2013), treatment retention in
mental health care (Tsan, Zeber, Stock, Sun, & Copeland, 2012), and increased utilization
of specialty mental health services (Wray, Szymanski, Kearney, & McCarthy, 2012).
It may be the case that inadequate power is behind the lack of differences detected
in this project as compared to previous research, as post-hoc power analyses indicated a
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particularly low likelihood of being able to detect differences in some utilization
variables (e.g., adequate mental health treatment; visits associated with specific mental
health diagnoses) even if differences were to be present. However, the implications of the
results of our moderated mediation analyses (as described below) may also be at play, in
which patient’s level of activation (i.e., engagement in health care) may be the driving
force between IMH treatment receipt and mental health care utilization.
We did find that Veterans in the IMH group filled less psychotropic prescription
medications, on average, then those in the UMH group in the year following treatment
initiation. These findings are inconsistent with some literature, which ascertains that IMH
treatment increases adherence to pharmacological treatment in other cohorts of Veterans
with mental health concerns (e.g., depression) (Fortney et al., 2011). However, various
complementary and alternative medicine (CAM) (e.g., meditation, mindfulness and
relaxation practices, yoga) treatment options are available for Veterans with PTSD
throughout the VA health care system (Libby, Pilver & Desai, 2012), and Veterans with
PTSD may benefit greatly from CAM modalities (Smeeding et al., 2010).
However, the results of the chart reviews conducted for the present study indicate
that, while treatment recommendations via psychotherapy may be similar between IMH
and UMH groups, CAM treatment modalities may be recommended as treatment options
more often in visits among Veterans receiving IMH treatment, while pharmacology may
be recommended for treatment more often in visits among Veterans receiving UMH care.
This is in line with literature finding that Veterans with PTSD receiving their care in
specialty mental health clinics (vs. Veterans receiving integrated mental health care)
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filled a greater number of psychotropic prescriptions (Vojvoda, Stefanovics, &
Rosenheck, 2014), and may be driving the presently observed differences in psychotropic
medication use between our IMH and UMH groups.
Since both IMH treatment delivery and offering CAM treatment modalities are
aspects of mental health care that are highlighted in efforts to create a patient-centered
care environment, it is not surprising that our results indicate that the two are related.
Further, literature indicates that Veterans who reported using CAM treatment modalities
were more likely to have PTSD than those who are not CAM users (Baldwin, Long,
Kroesen, Brooks & Belle, 2002), and that CAM use among persons with PTSD is high,
both along-side and instead of traditional treatment options (Libby, Pilver & Desai,
2013). This evidence indicates that some Veterans with PTSD may prefer to utilize CAM
treatment modalities over traditional PTSD treatment options. Accordingly, it may be the
case that providers delivering IMH treatment may be offering treatment modalities
alternative to medication for Veterans with PTSD in an effort to provide more patientcentered options for mental health care, and as such, driving down the rates of
pharmacology use among these patients.
Patient Preferences for Treatment
In line with the notion that CAM treatment modalities may be preferential
treatment options among persons with PTSD, and that CAM treatment modalities may be
recommended as treatment options more often in visits among Veterans receiving IMH
treatment, our visit-level data indicates that patient preferences for treatment were
discussed during a greater proportion of IMH visits than UMH visits as well. This is not
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surprising, as the consideration of patient preferences for treatment in treatment planning
and recommendations is an integral part of patient-centered care provision (IOM, 2001;
Barry & Edgman-Levitan, 2012) and a goal of the VA (VHA, 2014).
However, our visit-level chart review data also indicated that less than a quarter of
notes from primary care and mental health visits overall documented patient’s
preferences for mental health treatment; while a conversation about patient’s preferences
may not have been appropriate or natural during all visits reviewed as part of the data
collection process for this piece of the current study, this finding suggests that there may
be some room for improvement in discussing and considering patient’s preferences for
treatment among Veterans with PTSD during primary care and mental health visits.
There is some evidence that, when documenting details of mental health visits for
Veterans with PTSD, VA mental health care providers record information that they
believe is vital for them to remember in order to provide appropriate care for the patient,
while omitting details that they do not believe are vital for are improvement or may
actually hinder care provision (Tuepker et al., 2015). As such, improvement efforts
geared toward educating providers about the importance of discussing and considering
patient’s preference for treatment, and using that information to drive future treatment
and care planning efforts, may be warranted.
Furthermore, alignment of treatment with patient preferences for treatment has
been linked to increased engagement in care (Kwan, Dimidjian, & Rizvi, 2010) and
treatment adherence (Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008; Thompson,
& McCabe, 2012). It is therefore not surprising that in the present study, results indicate
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that there is a link between IMH treatment and both increased patient engagement (as
expanded upon below) and discussion of patient preferences for mental health care.
Alternatively, it may be the case that increased patient engagement empowers patients to
open up during visits with their VA providers and make their preferences for treatment
know, and that the differences observed in discussion of patient preferences for care were
patient driven rather than provider driven. In any case, overall, our patient-level data
suggest that the VA is doing very well at meeting patient preferences for treatment
overall, with no person-level differences observed between Veterans receiving IMH
compared to UMH in terms of the proportion of Veterans who had their mental health
preferences met over the course of their care in the year following treatment initiation.
Physical Health and Pain
The receipt of IMH treatment has been reported to be associated with
improvements in important health outcomes such as glycated hemoglobin A1c,
cholesterol, and blood-pressure levels in patients with chronic conditions (e.g., diabetes,
coronary heart disease (CHD) or both) and comorbid depression (Katon et al., 2010).
However, in the current project no differences were observed in proxy indicators of
physical health (e.g., the number of visits with poor health indicators for chronic
condition management of diabetes, hypertension, or hyperlipidemia) between Veterans
receiving IMH vs. UMH care. Additionally, IMH treatment receipt has been associated
with decreased pain among Veteran cohorts (Dobscha et al., 2009), but our findings did
not suggest differences in pain (baseline, last recorded, or pain difference scores) among
Veterans with PTSD who receive IMH compared to those who receive UMH care.
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Interestingly, though, Veterans in the IMH group reported marginally higher
physical health scores (as measured by the VR-12), on average, than those in the UMH
group; taken together, these findings suggest that aspects of physical health which may
not be captured via proxy measures of physical health may be improved in patients who
received IMH treatment over those who received UMH treatment. Additional research
may be warranted to examine the impact of IMH treatment receipt on a more
comprehensive gamut of factors related to physical health that may impact patient’s
perceptions of their physical health status, namely factors which may be most important
to patients regarding their physical health and functioning.
Mental Health Symptoms: Depression Symptom Severity, Self-Reported Mental
Health Scores, PTSD Symptom Endorsement and PTSD Symptom Severity
Prior literature has indicated that IMH treatment receipt may be effective in
reducing depression severity among Veteran cohorts (Dobscha et al., 2009), and PTSD
symptom severity in active duty military personnel (Engel et al., 2008; Cigrang et al.,
2011). Accordingly, we were expecting to observe higher self-reported mental health
scores, and lower depression and PTSD symptom severity among Veterans who received
IMH (vs. UMH care). Contrary to our expectations, however, no differences were
observed in patient’s perceptions of mental health status, depression (baseline, last
recorded, or PHQ-9 difference scores) or PTSD symptom severity (baseline, PCL
difference scores) among patients comprising our two Veteran groups.
Particularly for depression and PTSD symptom severity, however, multiple scores
were available for only a small number of participants. As such, results should be
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interpreted with caution, since they may not be representative of the actual severity of
depression and PTSD severity among all Veterans in the sample and further, may not be
generalizable to Veterans receiving VA mental health care in general. The limited
number of patients for whom multiple standardized assessments of symptom severity
were available may be a result of in-depth assessments of symptom severity not being
conducted, however, these ‘missing’ data may alternatively be a result of the provider
having conducted but failed to document such assessments, or results of the assessments,
in the note for that visits. However, these findings may corroborate recommendations that
system-wide, standardized screening and in-depth assessment procedures for mental
health diagnoses should be developed and implemented (Kearny, Wray, Dollar, & King,
2015).
We did find that Veterans in our two groups differed on endorsement of some
PTSD symptom clusters. Specifically, visit-level chart review data indicated that a
greater proportion of Veterans receiving IMH (vs. UMH) reported experiencing
symptoms consistent with intrusion, as well as alterations in arousal and reactivity, during
primary care or mental health encounters with VA providers. This is relatively surprising,
as IMH treatment is typically less intensive than specialty mental health care (Dundon,
Dollar, Schohn, & Lantinga, 2011; Possemato, 2011), and persons with more severe
symptoms who need more intensive treatment are usually referred out to specialty mental
health clinics (i.e., UMH). However, it is likely the case that, since IMH treatment is
associated with increased patient activation/engagement in care, Veterans receiving IMH
treatment may be more open/expressive about their symptom endorsement during health
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care encounters, thusly making it appear that they are more likely to endorse symptoms
when in actuality they are merely talking about their symptoms more openly.
Patient Perceptions of Patient-Centered Care Constructs Associated with the
Receipt of Integrative Mental Health Treatment
IMH treatment delivery within the VA health care system is a patient-centered
method of managing mental health concerns among Veterans, an integral facet to
ensuring that health care is being delivered in a truly patient-centered way (Croghan, &
Brown, 2010). Despite this, however, literature examining the relationship between
patient-centered care outcomes and IMH treatment receipt is lacking. Since IMH is a
patient-centered care related effort, we were expecting that patient’s perceptions of
patient-centered care constructs would be higher among Veterans who received IMH, as
compared to those who received UMH care.
Our data identified that following IMH treatment, Veterans with PTSD reported
higher levels of patient activation (i.e., engagement in their health care) than those who
received UMH care. These findings are concordant with the postulation that IMH
treatment increases engagement in mental health care among Veterans with mental health
concerns (Pomerantz, Kearney, Wray, Post, & McCarthy, 2014). Additionally, we found
that Veterans in the IMH group reported marginally higher perceptions of the decisionmaking effectiveness component of SDM, on average, than did Veterans in the UMH
group. One of the central tenets of the effectiveness of IMH treatment delivery is that it
reduces the stigma associated with seeking mental health care (Collins, Hewson, Munger,
& Wade, 2010; WHO, 2008). As such, it is likely the case that stigma reduction
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facilitates engagement in mental health care. In turn, decreased stigma and increased
engagement in care may catalyze Veterans with PTSD to actively participate in
conversations with their providers, thereby facilitating shared medical decision-making
and increasing patient’s satisfaction with the medical decision-making process.
The Relationship Between IMH Treatment and Receipt of Adequate Mental Health
Treatment in the Context of Patient Perceptions of Patient-Centered Care
Constructs
The mediation analyses conducted indicate that the pathway through which IMH
treatment may impact patient’s likelihood of receiving adequate mental health treatment
in the year following treatment initiation is not increased patient activation or shared
medication decision-making on their own. However, moderated mediation analyses
descriptively indicated that for patients receiving IMH treatment, perceptions of shared
medical decision-making (particularly the extent to which patients believe they were
presented with all possible treatment options, were involved in making a decision about
which treatment option/regiment was most suitable for them and were satisfied with the
treatment plan they came up with alongside their provider) may lead to adequate
treatment receipt for individuals who are highly engaged in their health care (e.g.,
reported high levels of patient activation), but not for patients with low levels of health
care engagement. In fact, the impact of shared medical decision-making on the
relationship between type of treatment received and subsequent receipt of ‘adequate’
mental health care was about 4 times larger in Veterans with high patient activation then
for those with low activation. Although our results were not reliably consistent with our
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predictions for moderated mediation, the absolute size of relationship differences might
merit further investigation.
A possible mechanism for this relationship begins with the association between
IMH and increased engagement in health care, which has been found among adults with
mental health concerns in the general population (Bartels, Coakley, Zubritsky, et al.
2004) as well as Veterans with mental health concerns (Pomerantz, Kearney, Wray, Post,
& McCarthy, 2014). Further, the results of the current study indicate that receiving IMH
care also leads to patients feeling more like their providers communicated effectively
with them and allowed them have a say in treatment decisions, a finding that is
corroborated with our chart review data, which suggests that patient preferences may
have been discussed more in IMH visits compared to usual care visits. Collectively,
increased engagement in mental health care may lead to an increased likelihood of
patients following up with mental health care needs, as well as empowering patients to
actively engage in conversations about treatment decision-making with their mental
health care providers. Simultaneously, the consideration of patient preferences in mental
health care treatment recommendations and providers engaging in shared medical
decision-making with patients may also lead to increased patient engagement in care, and
in turn, greater adherence to treatment regiments.
The lack of statistically significant findings in the moderated mediation analyses,
despite the fact that descriptively the findings appear indicative of a relationship being
present, may have more to do with lack of power then lack of an actual effect. In fact, the
relatively small sample size available for these analyses would only be adequately
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powered if a very large effect was present; given the effect sizes found in the mediation
analyses for the present study, a sample size of over 400 individuals would be needed to
detect a significant mediation effect (Fritz & MacKinnon, 2007). Given that the
mediation and moderated mediation analyses in the present study were dependent on a
sample less than 50 Veterans, a larger study may be warranted to give due diligence to
testing these relationships.
The results of the mediation and moderated mediation analyses conducted for the
present study may also shine some light on the potential reason behind some of the nonsignificant findings regarding general and mental health care utilization. For instance, the
proportion of our sample that reported high and low patient activation was relatively
equivalent (though overall patient activation was higher in those who received IMH
care). As activation seems to matter greatly in terms of which patients participate actively
in mental health care treatment for PTSD, it may be the case that patient activation
leveled out potential differences in various aspects of health care utilization between the
IMH and UMH groups, washing out potential (hypothesized) differences. Consequently,
the lack of differences in some facets of appropriate health care utilization (e.g., number
of filled prescriptions for medication) may be related to the lack of observed differences
in proxy indicators of physical health (e.g., chronic condition management indicators for
diabetes, hypertension and hyperlipidemia). As such, future research examining the
interplay between patient activation and health care utilization may be warranted with a
larger cohort of individuals, to allow for adequately powered multi-way crosstab analyses

105
to examine differences among utilization variables in Veterans who have PTSD with high
vs. low activation who receive IMH vs. UMH care.
Limitations
Several limitations to the current study should be noted. Specifically, in regard to
the data obtained via the patient-centered care survey, as with any self-reported survey
data this information may have been influenced by response bias and/or social
desirability bias. Further, as the instructions for the scales included in the patient-centered
care survey did not specify that questions related to mental health care, there is no way to
ascertain that participants were thinking about mental health care or interactions with
mental health care providers specifically when responding to the survey questions.
Additionally, the small sample size of the survey data coupled with a modest amount of
survey data, as well as the large amount of missing chart review data regarding
depression and PTSD symptom severity, limited both power and generalizability of the
results.
In regard to the chart review data, the lack of notation about patient preferences in
the notes documenting the primary care and mental health visits reviews does not
necessarily indicate that patient preferences were not actually discussed during the visit,
merely that they were not documented (e.g. full discussions/all details of visits may not
be reflected in the charts). Additionally, discussion of patient preferences for treatment
were not necessarily appropriate during all notes reviewed and included in analyses (e.g.,
primary care and/or mental health nursing encounters).
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Further, while the facilities designated ‘controls’ in this project may not have
been designated PCC COIs, it is possible that elements of PCC innovations were being
implemented at those facilities too. If control facilities knew of ongoing successful
innovations at the COIs and were practicing programs or elements of programs as well,
‘contamination’ of the control group may have occurred, and this may possible account
for some of the null findings in this study as well. Finally, the retrospective and
evaluative nature of this study, while affording the results great ecological validity, limit
the internal validity; therefore, we cannot ascertain that any of the differences observed
were a result of receiving IMH treatment.
Future Directions
While a number of potential focus areas have been identified by this project in
regard to future research which could be warranted and useful in the area of outcomes of
IMH treatment delivery, one overall recommendation is that a prospective study
following new Veteran patients with PTSD receiving IMH and UMH care, from
treatment initiation for at least one year may be warranted. This would allow for
systematic and controlled collection of baseline data, along with data at multiple points of
follow-up data, to identify differences in outcomes of interest. Additionally, a greater
amount of primary data collection would be useful to truly understand the impact of IMH
treatment delivery on patient’s perceived experiences with their VA mental health care.
Specifically, in-depth interviews with Veteran patients and providers, as well as a survey
focused entirely on perceptions of patient-centered care as it related to mental health care,
would provide rich detail about how the IMH mechanism affects the patient experience.
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Conclusions/Implications
Conclusions based on the present results are at best tentative and showed few
reliable advantages of IMH over UMH. However, combining behavioral health care with
traditional primary care through an integrative mental health treatment model may be
most effective in increasing health care engagement, shared decision-making, and
discussion of patient preferences for mental health care among Veterans with PTSD. As
such, these treatment efforts may be effective in increasing the number of Veterans who
receive appropriate, needed health care, as well as improving mental health care-related
satisfaction. However, data indicate that some targeted improvement efforts geared
toward educating providers about the importance of discussing and considering patient’s
preference for treatment, as well as implementing systematic collection of standardized
measures of symptom severity for common mental health concerns among Veterans
receiving VA health care, may be warranted. Collectively, integrating mental health care
providers into the primary care setting may be a good strategy for encouraging Veterans
with PTSD to seek out and stay the course of the treatment they need.
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Variable
Source
Demographics and Veteran Characteristics
Gender
VA Administrative Data
Age
VA Administrative Data
Race
VA Administrative Data
Ethnicity
VA Administrative Data
Marital Status
Service Connection

VA Administrative Data
VA Administrative Data

Chronic Conditions
Heart disease VA Administrative Data
Cancer VA Administrative Data
Chronic lower respiratory VA Administrative Data
disease

Stroke VA Administrative Data
Diabetes VA Administrative Data
Multimorbidity VA Administrative Data
Number of chronic VA Administrative Data
conditions
Comorbid Mental Health Diagnoses
Adjustment disorders VA Administrative Data

Anxiety disorders VA Administrative Data

PTSD VA Administrative Data

Specifications
Male; Female
Veteran’s age (continuous)
White; Black; Other
Hispanic/Latino; NonHispanic/Latino
Married; Not Married
Service Connected Disability
Percentage: 0%, 1-49%, 50100% (highest recorded)
ICD-9 codes: 402, 404, 410429
ICD-9 codes: 140-208, 238.6
ICD-9 codes: 490-496
*includes bronchitis,
emphysema, asthma,
bronchiectasis, extrinsic
allergic alveolitis, chronic
airway obstruction NOS
ICD-9 codes: 430-438
ICD-9 codes: 250
2 or more of the 2 chronic
conditions examined
Total number of chronic
conditions (continuous)
ICD-9 codes: 309.0, 309.1,
309.2, 309.21, 309.22, 309.23,
309.24, 309.29, 309.29, 309.3,
309.4, 309.82, 309.83, 309.89,
309.9
ICD-9 codes: 293.84, 300.00,
300.01, 300.02, 300.09,
300.10, 300.20, 300.21.
300.22, 300.29, 300.3, 300.5,
300.89, 300.9, 308.0, 308.1,
308.2, 308.3, 308.4, 308.9,
313.0, 313.1, 313.2, 313.21,
313.22, 313.3, 313.82, 313.83
ICD-9 codes: 309.81

110
Impulse control disorders VA Administrative Data
(including pathological
gambling)
Bipolar disorders VA Administrative Data

Depressive disorders VA Administrative Data

Personality disorders VA Administrative Data

Schizophrenia and other VA Administrative Data
psychotic disorders

ICD-9 codes: 312.30, 312.31,
312.32, 312.33, 312.34,
412.35, 312.39
ICD-9 codes: 296.00, 296.01,
296.02, 296.03, 296.04,
296.05, 296.06, 296.10,
296.11, 296.12, 296.13,
296.14, 296.15, 296.16,
296.40, 296.41 296.42, 296.43,
296.44, 296.45, 296.46,
296.50, 296.51, 296.52,
296.53, 296.54, 296.55,
296.56, 296.60, 296.61,
296.62, 296.63, 296.64,
296.65, 296.66, 296.67,
296.80, 296.81, 296.82,
296.89, 296.90, 296.99
ICD-9 codes: 293.83, 296.20,
296.21, 296.22, 296.23,
296.24, 296.25, 296.26,
296.30, 296.31, 296.31,
296.22, 296.34, 296.35,
296.36, 300.4, 311
ICD-9 codes: 301.0, 301.01,
301.11, 301.12, 301.13,
301.20, 301.21, 301.22, 301.3,
301.4, 301.50, 301.51, 301.59,
301.6, 301.7, 301.81, 301.82,
301.83, 301.84, 301.89, 301.9
ICD-9 codes: 293.81, 293.82,
295.00, 295.01, 295.02,
295.03, 295.04, 295.05,
295.10, 295.11, 295.12,
295.13, 295.14, 295.15,
295.20, 295.21, 295.22,
295.23, 295.24, 295.25,
295.30, 295.31, 295.32,
295.33, 295.34, 295.35,
295.40, 295.41, 295.42,
295.43, 295.44, 295.45,
295.50, 295.51, 295.52,
295.53, 295.54, 295.55,
295.60, 295.61, 295.62,
295.63, 295.64, 295.65,
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Substance use disorders VA Administrative Data

295.70, 295.71, 295.72,
295.73, 295.74, 295.75,
295.80, 295.81, 295.82,
295.83, 295.84, 295.85,
295.90, 295.91, 295.92,
295.93, 295.94, 295.95, 297.0,
297.1, 297.2, 297.3, 297.8,
297.9, 298.0, 298.1, 298.2,
298.3, 298.4, 298.8, 298.9
ICD-9 codes:
Alcohol: 291.0, 291.2, 291.2,
291.3, 291.4, 291.5, 291.8,
291.81. 291.82, 291.89, 291.9,
303.00, 303.01, 303.02,
303.03, 303.90, 303.91,
303.92, 303.93, 305.00,
305.01, 305.02, 305.03, 980.0
Substance: 292.0, 292.11,
292.12, 292.2, 292.81, 292.82,
292.83, 292.84, 292.85,
292.89, 292.9, 304.00, 304.01,
304.02, 304.03, 304.10,
304.11, 304.12, 304.13,
304.20, 304.21, 304.22,
304.23, 304.30, 304.31,
304.32, 304.33, 304.40,
304.41, 304.42, 304.43,
304.50, 304.51, 304.52,
304.52, 304.60, 304.61,
304.62, 304.63, 304.70,
304.71, 304.72, 304.73,
304.80, 304.81, 304.82,
304.83, 304.90, 304.91,
304.92, 304.93, 305.20,
305.21, 305.22, 305.23,
305.30, 305.31, 305.32,
305.33, 305.40, 305.41,
305.42, 305.43, 305.50,
305.51, 305.52, 305.53,
305.60, 305.61, 305.62,
305.63, 305.70, 305.71,
305.72, 305.73, 305.80,
305.81, 305.82, 305.83,
305.90, 305.91, 305.92,
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Suicide and intentional self- VA Administrative Data
injury

Military sexual trauma VA Administrative Data

Mental Health Services Utilization
Adequate mental health
VA Administrative Data
care utilization
Outpatient visits related to
mental health services

VA Administrative Data

Prescription psychotropic
medication fills

VA Administrative Data

Visits specifically
associated with mental
health conditions

VA Administrative Data

General Health Services Utilization
Inpatient visits
VA Administrative Data
Average length of stay VA Administrative Data

305.93, 648.30, 648.31,
648.32, 648.33, 648.34,
655.50, 655.51, 655.53,
965.00, 965.01, 965.02, 965.09
ICD-9 codes: E9500, E9501,
E9502, E9503, E9504, E9505,
E9506, E9507, E9508, E9509,
E9510, E9511, E9518, E9520,
E9521, E9528, E9529, E9530,
E9531, E9538, E9539, E954,
E955, E9551, E9552, E9553,
E9554, E9555, E9556, E9557,
E9559, E956, E9570, E9571,
E9572, E9579, E958, E9581,
E9582, E9583, E9584, E9585,
E9586, E9587, E9588, E9589,
E959, V6284
Positive answer provided to
VA Military Sexual Trauma
screener
9 or more mental health
treatment visits within 12
months of the patient’s index
Outpatient visits with primary
or secondary mental health
clinic stop
Antidepressants (CN600,
CN601, CN602, CN609);
Antipsychotics (CN700,
CN701, CN709); Anxiolytics
(CN300, CN301, CN302,
CN309); Stimulants (CN800,
CN801, CN802, CN809);
Lithium (CN750)
A visit will be considered to be
for a particular condition if the
primary diagnosis code for that
visit was an ICD-9 code for
that condition
Hospitalizations
Length of hospitalizations, if
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any
Outpatient visits (general)
VA Administrative Data
Primary care visits VA Administrative Data
Emergency department
VA Administrative Data
visits
Prescription medication fills VA Administrative Data
(general)
Physical Health (Clinical Indicators)
blood pressure
VA Administrative Data
(hypertension)

Hemoglobin A1c (diabetes)

VA Administrative Data

LDL (Hyperlipidemia)

VA Administrative Data

Mental Health Comorbidities
Pain Severity
Chart Review Data
Depression Severity
PTSD Symptoms
Symptom Endorsement

Chart Review Data
Chart Review Data

Number of visits associated
with poor condition
management: diastolic blood
pressure ≥ 90 and systolic
blood pressure ≥ 140
Number of visits associated
with poor condition
management: HbA1c ≥9%
Number of visits associated
with poor condition
management: LDL ≥ 130
0-10 rating scale of current
pain level
PHQ-9 score(s)

PTSD symptoms that the
patient is experiencing;
symptom clusters and
individual symptoms will be
recorded
Symptom Severity
Chart Review Data
PCL Score(s)
Provider Recommendations for Treatment and Patient Preferences
Provider’s treatment
Chart Review Data
Psychotherapy; Pharmacology;
recommendations
CAM
Patient preferences for
Chart Review Data
Based on a comprehensive
treatment
assessment of the content of
progress notes across the
course of treatment
Sub-Set Analysis of Patients for Whom CEPEP Survey Data Are Available
Self-Reported Health Status
Physical Health Summary
CEPEP Survey1
VR-12 PCS Score
Mental Health Summary
CEPEP Survey1
VR-12 MCS Score
Patient Perceptions of Patient-Centered Care Constructs
Satisfaction with health care CEPEP Survey1
Global Practice Experience
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facility
Perceptions of provider’s
empathy and patientprovider communication
Engagement in Health Care
Family involvement in care,
respect for choices, and
support
Perceptions of chronic
illness care
Shared decision-making

CEPEP Survey1
CEPEP Survey1
CEPEP Survey1
CEPEP Survey1
CEPEP Survey1

measure (GPE) score
Consultation and Relational
Empathy (CARE) score
Patient Activation Measure
(PAM) score
Press-Ganey Question score

Patient Assessment of Chronic
Illness Care (PACIC) score
Combined Outcome Measure
for Risk Communication and
Treatment Decision Making
Effectiveness (COMRADE)
score
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1. Patient problem list (Verbatim):
2. Index visit coded in the administrative data as:
☐ Integrative Mental Health (1)
☐ Control (Mental Health ‘Usual Care’) (0)
2a. If Control, what mental health clinic was the visit associated with?
PSYCHOLOGICAL COMORBIDITIES
3. Is there documentation of a validated PTSD assessment for this patient?
☐ Yes (1)
☐ No (0)
3a. If yes, which assessment was it:
☐ PTSD Checklist (PCL)
☐ Clinician Administered PTSD Scale (CAPS)
☐ PTSD Symptom Scale – Interview (PSSI)
☐ Other [*Specify:_____________]
3b. Score and provider notes regarding assessment (if any) and date the assessment was administered
(verbatim):

4. Is there documentation of an assessment of pain?
☐ Yes (1)
☐ No (0)
4a. If yes, copy pain score/content and date (verbatim):

5. Is there documentation of an assessment/diagnostic interview for depression?
☐ Yes (1)
☐ No (0)
5a. If yes, indicate name of assessment and score, and date (verbatim):

6. Is there documentation of an assessment/diagnostic interview for anxiety?
☐ Yes (1)
☐ No (0)
6a. If yes, indicate name of assessment and score, and date (verbatim):

7. Is there any documentation related to substance abuse?
☐ Yes (1)
☐ No (0)
7a. If yes, indicate details (verbatim):
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Appendix C. Chart Review Form
Integrative Mental Health in PTSD Chart Review Tool:
PTSD Symptoms – Frequency, Severity, Treatment Recommendations
2. Date of Visit: __ __\__ __\__ __ : 2. Date of note: __ __\__ __\__ __
3. Visit and provider type: ________

/ 4. Standard title: ________

5.Local title: _______

6. Does the note appear to include standard text (i.e. copy and pasted or repeated in other notes?) ☐ Yes
(1) ☐ No (0)
SYMPTOMS AT VISIT (check all that apply)
7. Did the note mention overall PTSD symptoms, in general:
☐ Yes
☐ No
7a. Did the note mention a change in overall PTSD symptoms, in general?
☐ Yes (From: ______________________ ) [Timeframe of change in symptoms, if mentioned]
☐ No
7d. Provider notes regarding overall PTSD symptoms, if any (verbatim):

8. Criterion B: Intrusion Symptoms – traumatic event is persistently re-experienced in the following
way(s)
☐ Symptom(s) present [go to question 8a]
☐ Not Mentioned [go to question 9]
☐ No symptoms [chart specified that no symptoms were present at this visit – go to question 9]
8a. Check all Intrusion Symptoms that are present (if any):
☐ Recurrent, involuntary, and intrusive memories
☐ Traumatic nightmares
☐ Dissociative reactions (e.g., flashbacks) which may occur on a continuum from brief episodes to
complete loss of consciousness
☐ Intense or prolonged distress after exposure to traumatic reminders
☐ Marked physiologic reactivity after exposure to trauma-related stimuli
☐ Other: ____________________________________________________________________
8b. Was a change in Intrusion Symptoms mentioned?
☐ Yes (From: ______________________ ) [Timeframe of change in symptoms, if mentioned]
☐ No

118
8c. Provider notes regarding intrusion symptoms, if any (verbatim):

9. Criterion C: Avoidance - Persistent effortful avoidance of distressing trauma-related stimuli after the
event
☐ Symptom(s) present [go to question 9a]
☐ Not Mentioned [go to question 10]
☐ No symptoms [chart specified that no symptoms were present at this visit – go to question 10]
9a. Check all Avoidance Symptoms that are present (if any):
☐ Trauma-related thoughts or feelings
☐ Trauma-related external reminders (e.g., people, places, conversations, activities, objects, or situations)
☐ Other: ____________________________________________________________________
9b. Was a change in Avoidance Symptoms mentioned?
☐ Yes (From: ______________________ ) [Timeframe of change in symptoms, if mentioned]
☐ No
9c. Provider notes regarding avoidance symptoms, if any (verbatim):

10. Criterion D: Negative Alterations in Cognitions and Mood - Negative alterations in cognitions and
mood that began or worsened after the traumatic event
☐ Symptom(s) present [go to question 10a]
☐ Not Mentioned [go to question 11]
☐ No symptoms [chart specified that no symptoms were present at this visit – go to question 11]
10a. Check all Symptoms of Negative Alterations in Cognitions and Mood that are present (if any):
☐ Inability to recall key features of the traumatic event (usually dissociative amnesia; not due to head
injury, alcohol or drugs)
☐ Persistent (and often distorted) negative beliefs and expectations about oneself or the world (e.g., "I am
bad," "The world is completely dangerous.")
☐ Persistent distorted blame of self or others for causing the traumatic event or for resulting consequences
☐ Persistent negative trauma-related emotions (e.g., fear, horror, anger, guilt or shame)
☐ Markedly diminished interest in (pre-traumatic) significant activities
☐ Feeling alienated from others (e.g., detachment or estrangement)
☐ Constricted affect: persistent inability to experience positive emotions
☐ Other:
_______________________________________________________________________________
10b. Was a change in Symptoms of Negative Alterations in Cognitions and Mood mentioned?
☐ Yes (From: ________________ ) [Timeframe of change in symptoms, if mentioned]
☐ No
10c. Provider notes regarding symptoms of Negative Alterations in Cognitions and Mood, if any
(verbatim):
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11. Criterion E: Alterations in Arousal and Reactivity - Trauma-related alterations in arousal and
reactivity that began or worsened after the traumatic event
☐ Symptom(s) present [go to question 11a]
☐ Not Mentioned [go to question 12]
☐ No symptoms [chart specified that no symptoms were present at this visit – go to question 12]
11a. Check all Alterations in Arousal and Reactivity Symptoms that are present (if any):
☐ Irritable or aggressive behavior
☐ Self-destructive or reckless behavior
☐ Hypervigilance
☐ Exaggerated startle response
☐ Problems in concentration
☐ Sleep disturbance
☐ Other:
________________________________________________________________________________
11b. Was a change in Symptoms of Alterations in Arousal and Reactivity mentioned?
☐ Yes (From: ______________ ) [Timeframe of change in symptoms, if mentioned]
☐ No
11c. Provider notes regarding symptoms of Alterations in Arousal and Reactivity, if any (verbatim):

12. Functional significance (i.e., significant symptom-related distress or functional impairment (e.g.,
social, occupational)) mentioned (verbatim):
☐ Not Mentioned
☐ No symptoms
13. Depersonalization (i.e., experience of being an outside observer of or detached from oneself (e.g.,
feeling as if "this is not happening to me" or one were in a dream) mentioned (verbatim):
☐ Not Mentioned
☐ No symptoms
14. Derealization (i.e., experience of unreality, distance, or distortion (e.g., "things are not real"))
mentioned (verbatim):
☐ Not Mentioned
☐ No symptoms
15. Did the patient display suicidal ideation?
☐ Yes (1)
☐ No (0)
☐ Not Mentioned
TREATMENT RECOMMENDATIONS
16. Did the note include any documentation related to recommendation(s) for treatment?
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☐ Yes (1)

☐ No (0)

16a. If yes, was the recommendation for: check all that apply
☐ Psychotherapy
☐ Pharmacology
☐ CAM (i.e., acupuncture, yoga, MBSR, etc.) [*Specify modality:_________]
16b. Provider recommendation(s) (verbatim):

17. Did the visit result in any consult(s) or referrals for future treatment?
☐ Yes (1)
☐ No (0)
17a. If yes, was the consult for: check all that apply
☐ Psychotherapy
☐ Pharmacology
☐ CAM (i.e., acupuncture, yoga, MBSR, etc.) [*Specify modality:_________]
17b. Provider consult(s) (verbatim):

18. Did the note include any documentation of current treatment?
☐ Yes (1)
☐ No (0)
18a. Provider’s details about current treatment (verbatim):

19. Communication about the patient’s preferences for treatment occurred.
☐ Yes (1)
☐ No (0)
19a. Details about provider’s probe and patient’s treatment preferences (verbatim):

APPENDIX C
PTSD CHECKLIST (PCL) - MILITARY VERSION
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Below is a list of problems and complaints that veterans sometimes have in response to a
stressful military experience. Please read each one carefully, put an “X” in the box.
A
Not
Quite a
little Moderately
Extremely
at all
bit
bit
Repeated, disturbing memories, thoughts, or images of a
stressful military experience?
Repeated, disturbing dreams of a stressful military
2.
experience?
Suddenly acting or feeling as if a stressful military
3. experience were happening again (as if you were reliving
it)?
Feeling very upset when something reminded you of a
4.
stressful military experience?
Having physical reactions (e.g., heart pounding, trouble
5. breathing, or sweating) when something reminded you of a
stressful military experience?
Avoid thinking about or talking about a stressful military
6.
experience or avoid having feelings related to it?
Avoid activities or talking about a stressful military
7.
experience or avoid having feelings related to it?
Trouble remembering important parts of a stressful military
8.
experience?
9. Loss of interest in things that you used to enjoy?
10. Feeling distant or cut off from other people?
Feeling emotionally numb or being unable to have loving
11.
feelings for those close to you?
12. Feeling as if your future will somehow be cut short?
13. Trouble falling or staying asleep?
14. Feeling irritable or having angry outbursts?
15. Having difficulty concentrating?
16. Being “super alert” or watchful on guard?
17. Feeling jumpy or easily startled?
1.

Has anyone indicated that you’ve changed since the stressful military experience?
Yes __ No__

APPENDIX D
CEPEP SURVEY WITH SCALES LABELED
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PATIENT-CENTERED CARE SURVEY
VETERAN PATIENT DEMOGRAPHICS AND CHARACTERISTICS ASSESSMENT (PDCA)
Please answer all questions. Your answers will be kept confidential.
(1) Have you seen a doctor or been in the hospital during the past 6 months (from about August 2012 until now – early 2013)?
 Yes, a VA doctor or VA hospital
(Please check all that apply)
 Yes, a non-VA doctor or non-VA hospital
 No, I have not seen a doctor or been in the hospital
(2) What is your gender?

 Male

(3) What is your age?

________ years

(4) Are you Hispanic or Latino?

 No

 Female

 Yes

 Don’t Know/Not Sure

(5) Which one of the following would you say best represents your race? (Please check one)
 White
 Native Hawaiian/Other Pacific Islander
 Black or African American
 American Indian or Alaska Native
 Asian
 Other (specify) _____________________________________________
 Don’t Know/Not Sure
(6) How much school have you completed? (Please check one)
 Did not complete elementary school
 High school graduate (grade 12 or GED)
 Elementary (grades 1 through 8)
 Some college or technical school
 Some high school (grades 9 through 11)
 College graduate (4 years or more)
(7) How would you describe your current relationship status? (Please check one)
 Married
 Member of an unmarried couple
 Separated/ Divorced
 Widowed
 Never married
(8) Which of the following most closely describes your usual living arrangements? (Please check one)
 Live alone
 Live with family, friend, spouse/other
 Live with formal (hired/paid) caregiver
 Other ____________________________________________ (please specify)
(9) On average, what is the distance between your home and the VA facility from which you
most often receive your care?
Please enter an answer and circle blocks or miles.
_________ blocks / miles
(10) On average, about how long does it take you to get from your home to the VA facility
from which you most often receive your care ?
(11) About how often do you typically access the Internet?






___________ minutes

Daily
Weekly
Please proceed to #12 and #13
Monthly
Less than once per month
I do not use/access the Internet (if selected this option, please skip to #14)

(12) Where do you most often access/use the Internet? (Please check one)
 Home
 Family/Friend’s home
 Work
 Public place (e.g., library, community center)
 Other, specify: ________________

 VA

(13) What do you use the Internet for?

(Please check all that apply)

 Email
 Health information

 Entertainment
 Social networking (e.g., Facebook)
 Other: ____________________

 News
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THE GLOBAL PRACTICE EXPERIENCE MEASURE
(14) Please indicate the extent to which you agree or disagree with the following statements:
Strongly
Disagree
Neutral
At my VA health care practice …
Disagree
I receive exactly the care I want and need when and how I



want and need it.
I am delighted with this practice.




Agree

Strongly
Agree









(15) Have you ever been asked by your VA facility to serve on a VA quality improvement committee, advisory
group, or decision-making team to represent the views of Veteran patients to improve care delivery?
 No
 Yes (please specify) _______________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
(16) Have you ever been asked (survey, interview) by your VA about your preferences for the design structure,
architecture, layout, etc. to enhance patient/family comfort, privacy, and/or convenience?
 No
 Yes (please specify) _______________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
(17) We are interested in knowing more about your general experience as a VA patient, in your own words.
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
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THE CONSULTATION AND RELATIONAL EMPATHY MEASURE (CARE)
Now, we would like you to please rate the following statements about your recent visit/clinical encounter to the VA.
Please check one box for each statement and answer every statement.

How was your VA health care provider at . . .
1. Making you feel at ease . . . . . .
(being friendly and warm towards you,
treating you with respect; not cold or abrupt)
2. Letting you tell your “story” . . . . . .
(giving you time to fully describe your illness in
your own words; not interrupting or diverting you)
3. Really listening . . . . . .
(paying close attention to what you were saying; not
looking at the notes or computer as you were talking)
4. Being interested in you as a whole person . . .
(asking/knowing relevant details about your life,
your situation; not treating you as “just a number”)
5. Fully understanding your concerns . . . . . .
(communicating that he/she had accurately understood
your concerns; not overlooking or dismissing anything)
6. Showing care and compassion . . . . .
(seeming genuinely concerned, connecting with you on
a human level; not being indifferent or “detached”)
7. Being positive . . . . . .
(having a positive approach and a positive attitude;
being honest but not negative about your problems)
8. Explaining things clearly. . . . . . . .
(fully answering your questions, explaining clearly,
giving you adequate information; not being vague)
9. Helping you take control . . . . . .
(exploring with you what you can do to improve your
health yourself; encouraging rather than “lecturing” you)
10. Making a plan of action with you . . .
(discussing the options, involving you in decisions as
much as you want to be involved; not ignoring your
views)

Poor

Fair

Good

Very
Good

Excellent

Does
Not
Apply
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PATIENT ACTIVATION MEASURE (PAM)
Below are some statements that people sometimes make when they talk about their health. Please indicate how much you agree or
disagree with each statement as it applies to you personally by circling your answer. Your answers should be what is true for you and not
just what you think the doctor wants you to say.
1.

When all is said and done, I am the person who is responsible for taking
care of my health.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

2.

Taking an active role in my own health care is the most important thing
that affects my health.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

3.

I am confident I can help prevent or reduce problems associated with my
health.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

4.

I know what each of my prescribed medications do.

Disagree

Agree

5.

I am confident that I can tell whether I need to go to the doctor or whether I
can take care of a health problem myself.

Disagree
Strongly
Disagree
Strongly

Disagree

Agree

Agree
Strongly
Agree
Strongly

6.

I am confident that I can tell a doctor concerns I have even when he or she
does not ask.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

7.

I am confident that I can follow through on medical treatments I may need
to do at home.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

8.

I understand my health problems and what causes them.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

9.

I know what treatments are available for my health problems.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

10. I have been able to maintain (keep up with) lifestyle changes, like eating
right or exercising.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

11. I know how to prevent problems with my health.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

12. I am confident I can figure out solutions when new problems arise with my
health.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

13. I am confident that I can maintain lifestyle changes, like eating right and
exercising, even during times of stress.

Disagree
Strongly

Disagree

Agree

Agree
Strongly

PRESS-GANEY PATIENT SATISFACTION SURVEY
Please select one answer for each (items a-f).
very
poor
poor
a. Degree to which you and your family were able to participate in decisions


about your care
b. How well staff explained their roles in your care


c.
d.
e.

Degree to which the staff supported your family throughout your healthcare
experience
Degree to which your choices were respected to have family members/friends
with you during your care
Degree to which staff respected your family’s cultural and spiritual needs

fair

good

very
good
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PATIENT ASSESSMENT OF CHRONIC ILLNESS CARE (PACIC)
Staying healthy can be difficult when you have a chronic condition. Now, we would like to learn about the type of help with your
condition you get from your health care team. This might include your regular doctor, nurse, or physician’s assistant who treats
your illness.
Over the past 6 months, when I received care for my chronic conditions, I was:

1. Asked for my ideas when we made a treatment plan.
2. Given choices about treatment to think about.
3. Asked to talk about any problems with my medicines or their effects.
4. Given a written list of things I should do to improve my health.
5. Satisfied that my care was well organized.
6. Shown how what I did to take care of myself influenced my condition.
7. Asked to talk about my goals in caring for my condition.
8. Helped to set specific goals to improve my eating or exercise.
9. Given a copy of my treatment plan.
10. Encouraged to go to a specific group or class to help me cope with
my chronic condition.
11. Asked questions, either directly or on a survey, about my health
habits.
12. Sure that my doctor or nurse thought about my values, beliefs, and
traditions when they recommended treatments to me.
13. Helped to make a treatment plan that I could carry out in my daily life.
14. Helped to plan ahead so I could take care of my condition even in
hard times.
15. Asked how my chronic condition affects my life.
16. Contacted after a visit to see how things were going.
17. Encouraged to attend programs in the community that could help me.
18. Referred to a dietician, health educator, or counselor.
19. Told how my visits with other types of doctors, like an eye doctor or
other specialist, helped my treatment.
20. Asked how my visits with other doctors were going.

None
of the
Time

A Little
of the
Time

Some
of the
Time

Most
of the
Time

Always

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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VR-12

This questionnaire asks for your views about your health. This information will help keep track of how you feel
and how well you are able to do your usual activities. Answer every question by marking the answer as indicated.
If you are unsure how to answer a question, please give the best answer you can. Please select only one answer
for each question.

1. In general, would you say your health is:

Excellent


Very Good


Good


Fair


Yes, limited
a lot

Yes, limited
a little

No,
not limited
at all













No,
none
of the
time


No,
none
of the
time

Yes,
a little
of the
time


Yes,
a little
of the
time

Yes,
some
of the
time


Yes,
some
of the
time

Yes,
most
of the
time


Yes,
most
of the
time

Yes,
all of
the
time


Yes,
all of
the
time













Not at all

A little bit

Moderately

Quite a bit



Extremel
y









2. The following questions are about activities you might do during
a typical day. Does your health now limit you in these activities?
If so, how much?
ACTIVITIES
a. Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling, or playing golf. .
b. Climbing several flights of stairs. . . . . . . . . . . ..
3. During the past 4 weeks, have you had any of the
following problems with your work or other regular daily activities
as a result of your physical health?
a. Accomplished less than you would like. . . . . . . . . .
b. Were limited in the kind of work or other activities. .
4. During the past 4 weeks, have you had any of the following
problems with your work or other regular daily activities as a
result of any emotional problems (such as feeling depressed or
anxious)?
a. Accomplished less than you would like. . . . . . . . . . .
b. Didn’t do work or other activities as carefully as usual
5. During the past 4 weeks, how much did pain interfere with
your normal work (including both work outside the home and
housework)?
These questions are about how you feel and how things have been
with you during the past 4 weeks. For each question, please give
the one answer that comes closest to the way you have been
feeling.
6. How much of the time during the past 4 weeks:
a. Have you felt calm and peaceful? . . . . . . . . . . . . .
b. Did you have a lot of energy? . . . . . . . . . . . . . . . . .
c. Have you felt downhearted and blue? . . . . . . . . . .
7. During the past 4 weeks, how much of the time has your
physical health or emotional problems interfered with your
social activities (like visiting with friends, relatives, etc.)?
Now, we’d like to ask you some questions about how your health
may have changed.
8. Compared to one year ago, how would you rate your physical
health in general now?
9. Compared to one year ago, how would you rate your
emotional problems (such as feeling anxious, depressed or
irritable) now?

All
of the
time




Most
of the
time




A good
bit of
the time




Some
of the
time




A little
of the
time




Poor




None
of the
time




All of
the time


Most of
the time


Some of
the time


A little of
the time


None of
the time


Much better

Slightly
better

About the
same

Slightly
worse

Much
worse
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THE COMBINED OUTCOME MEASURE FOR RISK COMMUNICATION AND TREATMENT DECISION
MAKING EFFECTIVENESS (COMRADE)
Please respond to the following statements by circling the number on the scale (1 to 5) that best agrees with your view. If
you are not completely sure about an answer please circle the number which represents your best guess. An example of
how to answer a question is shown here:
I have been to the doctor often in the last year
Strongly
Strongly
disagree
agree
1
2
3
4
5
Here we refer often to “treatments” and “choices about treatment”. One of these choices may be not to take treatment, or it may be
that the decision was left until another time. Whichever plan was made, please still answer all questions.
1. The doctor made me aware of the different treatments available

2. The doctor gave me the chance to express my opinions about the
different treatments available

3. The doctor gave me the chance to ask for as much information as I
needed about the different treatment choices available

4.The doctor gave me enough information about the treatment choices
available
5. The doctor gave enough explanation of the information about the
treatment choices
6. The information given to me was easy to understand

7. I know the advantages of treatment or not having treatment

8. I know the disadvantages of treatment or not having treatment

9. The doctor gave me a chance to decide which treatment I thought was
best for me
10. The doctor gave me a chance to be involved in the decisions during
the consultation

Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1

2

2

2

2

2

2

2

2

2

2

3

3

3

3

3

3

3

3

3

3

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5
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11. Overall I am satisfied with the information I was given

12. My doctor and I agreed about which treatment (or no treatment) was
best for me
13. I can easily discuss my condition again with my doctor

14. I am satisfied with the way in which the decision was made in the
consultation
15. I am sure that the decision made was the right one for me personally

16. I am satisfied that I am adequately informed about the issues
important to the decision
17. It’s clear which choice is best for me

18. I’m aware of the treatment choices I have

19. I feel an informed choice has been made

20. The decision shows what is most important for me

Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1
Strongly
disagree
1

2

2

2

2

2

2

2

2

2

2

3

3

3

3

3

3

3

3

3

3

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5

4

Strongly
agree
5
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